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ABSTRACT 
 
           Recent studies suggest that some cases of prenatal depression may be associated with 
reactivation of latent infections of the herpesvirus family. The possible relationships among 
stress, prenatal depression, and herpes viral reactivation in pregnancy are understudied and the 
molecular pathways such as the neuroimmune biogenic amine pathway are unidentified. Chronic 
stress shifts the T helper-1 cell (Th1) cytokine profile to a Th2 profile, which favors virus 
induced pathogenesis and survival. Pregnancy is also associated with a similar Th2 dominance. 
In non-pregnant individuals, exposure to psychological or physical stress may be associated with 
latent herpes viral reactivation and could result in behavioral deficits and depression. Normally, 
type-1 cytokines such as Interferon-γ (IFN-γ) and inflammatory cytokines such as tumor necrosis 
factor-α (TNF-α) induce indoleamine-2, 3-dioxygenase (IDO) activation which inhibits herpes 
virus replication and reactivation, decreases tryptophan production, and alters phenylalanine 
/tyrosine metabolism. Thus it is possible that prenatal depression may occur from tryptophan 
stealing through the IDO pathway which results in decreased serotonin as well as increased risk 
for latent herpes viral reactivation. 
           The purpose of this study is to analyze the relationships among stress, herpes viral titers, 
depression, and metabolites of IDO activation, which involves tryptophan and guanosine-
triphosphate-cyclohydrolase-1(GTP-CH1) pathways. This study builds on Influence of Lactation 
on Postpartum Stress and Immunity (Grant number: R01-NR05000) which investigated perinatal 
immune, endocrine, and inflammatory changes in pregnancy and the postpartum. A secondary 
xiii 
 
data analysis was conducted on baseline data from women collected at 16 to 25 gestational 
weeks. This data set included some herpes viral titers, and additional ones were measured in 
stored plasma samples. The aim of this study is to examine relationships among stress, herpes 
viral reactivation, depression, and the IDO activation pathway. The results of this study provide 
information about the possible role of further relationships of prenatal stress, latent herpes viral 
reactivation, and depression mechanisms. The results will be important in health promotion and 
disease prevention during pregnancy. 
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CHAPTER ONE  
 
INTRODUCTION 
 
           Pregnancy is a vulnerable time for women. Physiological changes in pregnancy include a 
general suppression of type 1 immunity and a favoring of type 2 immunity along with a 
generalized but highly regulated inflammatory state (Mor & Cardenas, 2010; Rusterholz, Hahn 
& Holzgreve, 2007). Type1 immunity includes both the T helper -1 (Th1) axis which favors 
cellular cytotoxicity and promotion of innate immunity and secretion of type -1 cytokines 
(Interferon-γ (IFN-γ), IL-2, IL-12) from multiple other sources. Type 2 immunity is considered 
anti- inflammatory and includes both the T helper-2 (Th2) axis and secretion of type- 2 cytokines 
(IL-4, IL-5, and IL-13) from multiple other sources. The immune changes of pregnancy mimic in 
some sense how the immune system responds to chronic stress. Chronic stress induced immune 
dysregulation results in elevation of the inflammatory markers interleukin-6 (IL-6), IL-1β, tumor 
necrosis factor-α (TNF-α), and C-reactive protein (CRP) (Coussons-Read, Okun & Nettles, 
2007; Hansel, Hong, Camara & Kanel, 2010) which promotes latent herpes viral reactivation 
(Gesser, 1997; Miller & Cohen, 2005), increasing the risk of infection and behavioral and 
cognitive deficits (Godbout & Glaser, 2006; Haeri et al., 2011). 
           Psychosocial stress during pregnancy is a strong predictor of prenatal depression (Woods, 
Melville, Guo, Fan & Gavin, 2010; Escriba-Aguir, Royo-Marques, Artazcoz, Romito & Ruiz-
Perez, 2012). Depression is one of the most common complications in pregnancy and as many as 
20 percent of pregnant women experience it (Bonari, Pinto, Ahn, Einarson, Steiner & Koren, 
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2004; Groer et al., 2011). Prenatal depression increases the risks of developing postpartum 
depression. Prenatal depressive symptoms include sleep disturbance, lack of energy, and appetite 
changes. Depressive symptoms may associate with fatigue symptoms, for example Fagundes and 
colleagues (2012) reported that people with higher levels of depressive symptoms had greater 
fatigue symptoms. Fatigue symptoms include sleep disturbance, headache or musculoskeletal 
pain. These common symptoms may be unrecognized or misinterpreted as normal experiences of 
pregnancy (Marcus, 2009); however, unrecognized or untreated prenatal depression contributes 
to suicide, which is one of the leading causes of maternal death (Oates, 2003; Lindahl, Pearson & 
Colpe, 2004). Other negative pregnancy outcomes affected by depression include: preterm labor, 
low birth weight, and behavioral abnormalities in offspring (Buka, Cannon, Torrey & Yolken, 
2007; Christian, 2012; Gennaro & Hennessy, 2003; Markham & Koenig, 2011; Schetter, 2011; 
Buka et al., 2001). 
           Herpes viruses have the ability to establish a long-term latent infection and to escape 
reactivation through host cellular immune surveillance. Latently infected cells may be stimulated 
during physiological or psychological stress to increase viral transcription, resulting in 
production of infectious virions which leads to either asymptomatic virus shedding or disease 
recurrence (Gesser, 1997).  
           Evidence suggests that psychosocial stress triggers immune system dysregulation which is 
associated with acute and chronic herpes infection (Miller & Cohen, 2005). Although important 
studies about stress and acute infection in humans that include the British common cold study 
(Cohen, Tyrrell & Smith, 1991) and the Pittsburgh influenza study (Cohen, Doyle & Skoner, 
1999) have been conducted, they only examine general populations and fail to specify pregnant 
women as unique patients. Human studies about stress and chronic latent infectious disease 
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include oral herpes studies (Katcher et al., 1973), genital herpes studies (Goldmeier & Johnson, 
1982), and ocular herpes studies have similar emphases. Very limited research has examined 
stress and immune dysregulation induced latent herpes viral reactivation in pregnant women. 
           Indoleamine-2, 3-dioxygenase (IDO) is an immunoregulatory enzyme which balances 
immunity and tolerance to reduce harm from pathogens that affects the biogenic amines 
pathway. IFN- γ and TNF-α have been shown in HeLa cells and astrocytoma cell cultures 
infected with  herpes simplex virus type 2 (HSV-2) , to activate IDO which inhibit herpes 
simplex virus (HSV) replication (Adams, Besken, Oberdorfer, Mackenzie, Takikawa & 
Daubener, 2004). Stress dysregulation of the cellular immune response affects in both pathways, 
inducing tryptophan degradation in the IDO /tryptophan-2, 3-dioxygenase (TDO) pathway and 
activating  phenylalanine to tyrosine enzymes in the guanosine-triphosphate-cyclohydrolase-
1(GTP-CH1) pathway (Schrocksnadel et al., 2003; Capuron et al., 2011). T cells and natural 
killer (NK) cells secrete IFN-γ to induce IDO activity, which catalyzes tryptophan to break down 
to kynurenine, decreasing serotonin synthesis. 
           Although TDO follows the same pathway as IDO and both will break down tryptophan to 
kynurenine, this paper limits its focus to IDO. Enhanced neopterin and nitrite concentration, as 
well as decreased tyrosine levels, affect norepinephrine and dopamine synthesis, which is 
correlated to sleep disturbance, fatigue, gastrointestinal and muscular skeletal symptoms 
(Capuron et al., 2011; Schrocksnadel et al., 2003; Littrell, 2012; McTavish, Mannie, Harmer & 
Cowen, 2005; Scrandis et al., 2008; Widner, Laich, Spemer-Unterweger, Ledochowski & Fuchs, 
2002).  There is a lack of research findings on the relationship between IDO activity and GTP-
CH1 in latent herpes viral reactivation and prenatal depression. 
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Statement of the Problem 
           In the general population, stress results in herpes viral reactivation. Psychosocial stress 
during pregnancy is a strong predictor of prenatal depression, and unrecognized prenatal 
depression contributes to suicide, which is the second most common cause of perinatal death 
(Oates, 2003; Lindahl, Pearson & Colpe, 2004). Prenatal depression needs to be addressed as it 
relates to herpes viral titers. 
Purpose Statement 
           The purpose of this study is to identify the relationships among psychosocial stress, 
depression, herpes viral titers and biogenic amines in the second trimester of pregnancy. This 
study builds on Influence of Lactation on Postpartum Stress and Immunity (Grant number: 
R01NR005000).  
Specific Aims 
           The specific aims are to analyze the relationships among stress, depressive symptoms, 
herpes viral titers, and metabolites of the IDO and GTP-CH1 pathways. The central hypothesis in 
this study is that prenatal psychosocial stress induces herpes viral reactivation through type-1 
immune suppression and tryptophan degradation through the IDO pathway. The tryptophan 
degradation decreases serotonin synthesis which possibly accelerates depressive symptoms. It is 
hypothesized that stress favors reactivation of latent herpes viruses in pregnant women because 
they are vulnerable to stress. This hypothesis is formulated on the basis of data collected in the 
parent study (R01-NR005000) which investigated perinatal immune, endocrine and 
inflammatory changes in pregnancy and the postpartum period as well as reviews of the 
literature.  
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           The current study examined previously assayed herpes viral: herpes simples virus type 1 
(HSV-1), herpes simplex virus type 2 (HSV-2), human herpes virus-6 (HHV-6) and 
cytomegalovirus (CMV) IgG titers from women at 16 to 25 gestational weeks and measured 
Epstein- Barr virus (EBV) antibody IgG titers in frozen plasma samples from these same women 
and the resulting information were added to the data base.  
Hypotheses to be tested include: 
Hypothesis 1: There is a significant positive relationship between stress and depressive 
symptoms in pregnant women. 
Hypothesis 2: There are significant positive relationships among herpes viral titers, stress and 
depressive symptoms in pregnant women. 
Hypothesis 3: The kynurenine /tryptophan ratios and phenylalanine /tyrosine ratios, and 
neopterin levels are positively related to herpes viral titers in depressed pregnant women. 
Definitions of Relevant Terms 
The relevant terms in this study will be referenced as following:  
           Stress. Stress is defined as “the circumstance, characteristics, and events which constitute, 
or are perceived to constitute, a threat to survival or well-being” (Walker, Green, Greenman, 
Walker & Sharp, 2005, p. 141). Hans Selye (1976) initially defined stress as a physical reaction 
to change as hypothalamic-pituitary-adrenal (HPA) and sympathoadrenomedullary (SAM) are 
co-activated and mediated in the immune system. Psychological stress can result from 
experience such as major life events, abuse, trauma, and environmental factors, and it is 
measured by the Perceived Stress Scale (PSS) in this study. 
           Latent viral reactivation and antibody titers. According to Miller and Cohen (2005) 
and Sinclair (2008), after primary infection, human herpes virus establishes a latent infection 
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under the control of a healthy immune surveillance. During latency, the virus maintains its 
genome without production of infectious virions. However, latent virus production ceases and 
does not aggravate illness symptoms in immune-competent individuals. This latent or clinically 
silent period can last for years or a lifetime.  
           Latent viral reactivation occurs under certain conditions, such as in immune-compromised 
individuals, and can result in serious diseases. Recent studies revealed that latent viral 
reactivation mechanism is linked to an epigenetic process that occurs after integrating genetic 
material into host cells (Weekes et al., 2013; Knipe et al., 2013; Liu, Wang, Yan, Zhang, 
Abecassis & Hummel, 2013; Woellmer & Hammerschmidt, 2013).  
           Latent herpes viruses can be reactivated and then begin replication at any time and trigger 
symptomatic clinical illness; for example, HSV-1 causes cold sores and encephalitis, HSV-2 
causes genital lesions, HHV-6 causes encephalitis, hepatitis, and disseminated diseases, EBV 
causes infectious mononucleosis, Burkitt’s lymphoma, Hodgkin’s disease, and nasopharyngeal 
carcinoma, and CMV causes conjunctivitis and other conditions (Miller & Cohen, 2005; Murata 
& Tsurumi, 2013).  
           However, not all reactivated herpes viruses cause clinical illness even when there is 
evidence of reactivation. Operationally, latent viral reactivation is measured by viral antibody 
production. Elevation of antibody titers shows increasing viral replication; the high titers of 
herpes specific antibodies are an indication of ineffective cellular immune control of the virus.  
           Depression. Depression is a mood disturbance characterized by changes in mood, loss of 
interest or pleasure, cognitive function, sleep, appetite, and energy level ((Pratt & Brody, 2008). 
According to Diagnostic and Statistical Manual of Mental Disorder (DSM-IV, 2000) criteria, 
“depressive disorder is a period of at least two weeks of feeling sadness, hopelessness, and 
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discouragement. The individual should also experience at least four additional symptoms 
including: changes in appetite or weight, sleep and psychomotor activity, decreased energy, feels 
of worthlessness or guilt, difficulty thinking, concentrating or making decision, or recurrent 
thoughts of death or suicidal ideation or suicide attempt” (p.349). Depression in this study is 
measured by Profile of Mood States Depression /Dejection subscale (POMS-D). Refer to chapter 
3 methods. 
Significance to Nursing 
           Pregnant women make up a major vulnerable population for stress induced diseases. 
Stressful events, poor coping skills, lack of social support, and availability of resources can 
affect immune function which increases the susceptibility to infectious diseases and depressive 
episodes. Because of the relationship between psychosocial stress -induced latent herpes viral 
reactivation and depression, emotions affect infectious diseases progression which in turn 
complicates mental illness.  
           The biochemical and immune alterations of pregnancy may play roles in prenatal 
depression, which affects multiple pregnancy outcomes and are predictor of postpartum 
depression. This nursing research may lead to improved health care by integration of biological 
tool such as biomarkers with behavioral assessment. Prenatal depression needs to be addressed as 
a specific health problem in a vulnerable time in women’s lives. The results will be significance 
in guiding health promotion and disease prevention during pregnancy. 
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CHAPTER TWO  
REVIEW OF THE LITERATURE 
           This chapter reviews literature that is relevant to the study. Topics are focused on (1) 
overall relationships between stress, depression and infection; (2) body mass index and 
depression; (3) pregnant women’s immune systems; (4) stress-induced immune dysregulation; 
(5) immune dysregulation and herpes viruses; (6) herpes viral reactivation; (7) neuroimmune 
pathways and depression; and (8) herpes viruses, indoleamine-2, 3-dioxygenase (IDO) activation 
and depression. The stress induced immune response inhibits herpes viral replication by 
increasing IDO activity and possibly accelerating depressive symptoms. 
 
Conceptual/Theoretical Framework  
           The bio-behavioral framework of this study is presented in Figure 1. Prenatal 
psychosocial stress and the normal physiology of pregnancy induces a shift from a type 1 to a 
type 2 adaptive immune profile and a state of controlled inflammation, a profile which favors 
latent herpes viral reactivation. Inflammatory factors, high levels of cortisol, and IDO activation 
in pregnancy reduce available tryptophan which decreases the likelihood of viral replication and 
affects serotonin synthesis as well as phenylalanine and tyrosine metabolism.  
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           Figure 1. Relationship of prenatal stress, depression and herpes viral reactivation 
Body Mass Index and Depression  
           The association between body mass index (BMI; kg /  ) and depression in non-pregnant 
women has been previously reported (Onyike et al., 2003; Ma & Xiao, 2010). A recent study 
reported an association between obesity and suicidal ideation among US adult women (Zhao et 
al., 2012). Studies on the relationships between BMI and depression in pregnant women found 
inconsistent results.  
           LaCoursiere and colleagues (2006) reported that maternal BMI was related to postpartum 
depression studied in a large sample (N = 3,439). Bodnar and colleagues (2009) reported that 
pre- pregnancy obesity was associated with depression during pregnancy. LaCoursiere and 
colleagues in a later study (2010) (N = 1,053) also found that pre-pregnancy high BMI was 
related to postpartum depression. Contrary to LaCoursiere and colleagues (2006, 2010) and 
Bodnar (2009) studies, Haeri and colleagues (2011) reported lower BMI in a depressed pregnant 
women group (N = 100) than in non-depressed pregnant women group. Cassidy-Bushrow and 
colleagues (2012) also found that BMI did not mediate depressive symptoms in African-
American pregnant women (N = 187).   
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Prenatal Stress, Depression and Infection 
           Psychosocial stress during pregnancy is a predictor of prenatal depression. Studies support 
a link between stress and depression in animal models (Markham & Koenig, 2011; Christian, 
2012). However, limited data are available on relationships among stress, immune regulation, 
and depression in pregnant women. In maternal health there are limited studies with large 
samples or with prospective samples over 12 months of follow up. Recent studies by Woods and 
colleagues (2010) and Escriba-Aguir and colleagues (2012) showed common risk factors for 
maternal stress such as age, life events, low social support, maternal anxiety, and history of 
depression. 
           Prenatal depression occurs in up to 20 % of pregnancies and is influenced by hormonal, 
social, and genetic factors. Untreated prenatal depression contributes to postpartum depression 
(PPD), suicide events, preterm labor, and negative pregnancy outcomes (Oates, 2003; Lindahl, 
Pearson & Colpe, 2004; Bonari, Pinto, Ahn, Einarson, Steiner & Koren, 2004; Buka, Cannon, 
Torrey & Yolken, 2007; Marcus, 2009; Markham & Koenig, 2011). Prenatal depression is 
related to cortisol, dopamine, and serotonin monoamine neurotransmitters resulting in negative 
outcomes such as fetal growth delay, prematurity, and low birth weight (Field, Diego & 
Hernandez-Reif, 2010).  
           Evolutionary theories of depression developed from monoamine hypothesis, cytokine 
hypothesis, sickness behavior, and neuro-immune modulation to more recent “infection-defense 
hypothesis” or “pathogen host defense (PATHOS-D)” theory (Anders, Tanaka & Kinney, 2013; 
Raison & Miller, 2013). This “infection-defense hypothesis” states that depression is a 
behavioral response to help the immune system to fight with existing infection and to avoid 
additional exposure to pathogens. Increased exposure to infectious pathogens was associated 
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with increased rates of depression; the hypothesis is that risk of depression is due to individual 
immune system vulnerability to infectious pathogens or that individual carries depression risk 
candidate genes.  
           There are recent studies indicating that infections are associated with depression, for 
example, herpes simplex virus type 2 (HSV-2) infection was associated with depression in the 
general population (Pratt, Xu, McQuillan & Robitz, 2012), Epstein-Barr virus (EBV) and 
cytomegalovirus (CMV) reactivation were associated with inflammation and depression in older 
adults (Bennett et al., 2012). Depression in pregnant women was associated with influenza virus 
(Christian et al., 2010), EBV (Border et al., 2010; Haeri et al., 2011), human immunodeficiency 
virus (HIV) (Ross, Sawatphanit & Zeller, 2009) and Toxoplasma gondii infection (Groer et al., 
2011). Additionally, in African American pregnant women depression was associated with EBV 
reactivation (Christian, Iams, Porter & Glaser, 2012; Haeri et al., 2011). 
Immune Regulation in Normal Pregnancy 
           During pregnancy, the immune system plays an important role in avoiding rejection of the 
fetus. The theory of pregnancy immune tolerance views the fetus as a semi-allogeneic graft. 
There is reduced fetal trophoblastic cell membrane human leukocyte antigens (HLA) expression 
(Chen, Liu & Sytwn, 2012; Rusterholz, Hahn & Holzgreve, 2007). In addition, soluble factors 
from trophoblastic cells, such as IDO, inhibit maternal T cell proliferation and decrease natural 
killer (NK) cytotoxicity and interferon- γ (IFN-γ) production to avoid rejection of the fetus in 
early pregnancy (Chen, Liu & Sytwn 2012; Rusterholz, Hahn & Holzgreve, 2007).  
           During the first and third trimesters there is an up -regulated inflammatory state (Mor & 
Cardenas, 2010) as well as expression of cytotoxic T lymphocyte antigen (CTLA)-4 on T 
regulatory cells to induce monocyte and dendritic cell IDO activation, which is required to 
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maintain immunologic homeostasis during pregnancy (Chen, Liu & Sytwn, 2012). Because this 
process leads the placenta to secrete IDO, and IDO steals the essential amino acid tryptophan 
from T cells, it can result in decrease levels of serotonin, which is linked to depression.  
Stress-Induced Immune Dysregulation 
           Miller, Maletic and Raison (2009) pointed out that many studies that recognized 
depression in non-pregnant individuals were associated with an inflammatory process that may 
be induced when stress stimulates the inflammatory transcription factor, nuclear factor kappa B 
(NF- κ B), through the sympathetic nervous system. It has also been found that stress increases 
glucocorticoid and catecholamine production, suppresses neutrophil and NK activity, elevates 
inflammatory cytokines, and shifts immunity to a type -2 cytokine profile. This immune response 
during a stressful event could change neurotransmitter balance, resulting in vulnerability to 
depressive symptoms and herpes viral reactivation (Black, 1994; Borders et al., 2010; Groer, 
Meagher & Kendall-Tackett, 2010; Padgett & Glaser, 2003; Segerstrom & Miller, 2004; Steptoe, 
Hamer & Chida, 2007; Haroon, Raison & Miller, 2012; Littrell, 2011; Miller, Maletic & Raison, 
2009; Reiche, Nunes & Morimoto, 2004; Messay, Lim & Marsland, 2012; Bao, Meynen & 
Swaab, 2008; Christian, 2012; Hansel, Hong, Camara & Kanel, 2010; Godbout & Glaser, 2006).  
           Whether these same phenomena occur in pregnancy is largely unknown, as only a few 
studies with small sample sizes have been reported. Coussons-Read and colleagues (2005, 2007) 
reported that significantly high levels of perceived stress during the first and third trimester of 
pregnancy (N = 24) resulted in increased circulating levels of C-reactive protein (CRP) and pro-
inflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factor- α (TNF-α), and 
decreased  levels of the anti-inflammatory cytokine IL-10. Christian and colleagues (2009) 
reported in a sample size of 60 that depressive symptoms were significantly associated with IL-6, 
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TNF-α at 15 weeks of gestation. Conflicting data was reported from Blackmore and colleagues 
(2011), as they did not find a relationship between depression and pro-inflammatory cytokines in 
pregnant women.  
Immune Dysregulation and Herpes Viruses 
           The stress-induced immune shift of cytokines from the Th1 to the Th2 profile favors virus 
reactivation. For example, psychosocial stress was associated with increased IL-6 and CRP 
levels which prompted depression or latent virus reactivation in the general population (Bennett 
et al., 2012; Gouin, Glaser, Malarkey & Beversdorf, 2012; Fagundes, Glaser, Hwang, Malarkey 
& Kiecolt-Glaser, 2013). Hypotheses on the impact of stress on viral reactivation began in the 
early 1970s. Gesser (1997) reported that there was potential to synthesize fully infectious viruses 
under permissive conditions during the latency stage of herpes viral infection. Latently infected 
cells may be provoked by physiological or psychological stimuli, hypothalamic-pituitary-adrenal 
(HPA), and glucocorticoid hormones to produce infectious virions, which can lead to either 
asymptomatic virus shedding or disease recurrence (Pereira et al., 2003). 
           Evidence from human studies suggests that stressful experiences increase vulnerability to 
viral infections including chronic herpes viral reactivation (Cohen, Tyrrell & Smith, 1991; 
Katcher, Brightman, Luborsky & Ship, 1973; Goldmeier & Johnson, 1982; Cohen, Doyle & 
Skoner, 1999; Glaser et al., 1999; Chida & Mao, 2009). Glaser and colleagues (1999) observed a 
relationship between psychological stressor and herpes viral (HSV-1, HHV-6, EBV) 
reactivation. Although Phillips and colleagues (2008) conducted a study of the relationship 
between older adults’ CMV antibodies titers and depressive symptoms, it design did not 
adequate measure stress and latent herpes viral reactivation.   
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           The possibility that physical and psychosocial stress can induce immune dysregulation 
and latent viral reactivation in pregnancy is largely unknown and no studies have examined the 
effect of stress, depressive symptoms and herpes viral titers in pregnant women. A few studies 
reported that perceived stress was associated with pro-inflammatory and anti-inflammatory 
cytokines in pregnant women; Christian and colleagues (2009) reported that immune alteration 
has a negative effect on response to infectious pathogens during pregnancy.  
           Two recent studies reported that chronic stress induced EBV antibody titer elevation is 
associated with maternal depression (Borders et al., 2010; Haeri et al., 2011). These data provide 
evidence of a link between maternal stress, depression, and viral reactivation; however, further 
studies are needed to evaluate the bio-behavioral pathways. 
Herpes Viral Reactivation  
           Herpesviridae is a double-stranded DNA enveloped virus. Herpes virus family members 
(HSV-1, HSV-2, CMV, HHV-6, and EBV) are a leading cause of human viral diseases. These 
herpes viruses are infecting in the human central nervous system. After infection, viruses 
replicate and integrate their DNA into the host genome. Once integrating, viruses establish long-
term latent infection and are capable of escaping host cell immune surveillance.  
           There is more evidence showing that neurotropic potential herpes viruses are related to 
psychiatric disorders; for example, Dickerson and colleagues (2003) found that HSV-1 
seropositivity is an independent predictor of cognitive dysfunction in schizophrenia patients. 
Buka and colleagues (2007) reported that mothers with HSV-2 infection were at significantly 
increased risk of their offspring developing psychosis. CMV and EBV are related to stress, 
anxiety, depression and fatigue syndrome in elderly or cancer patients (Fagundes et al., 2012; 
Bennett et al., 2011). Recently, Carter (2013) reported that maternal HSV-1 infection could 
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affect fetal neurodevelopment or adult psychiatric and neurological disorders through a 
host/pathogen interactome and susceptibility genes interaction, resulting in direct or collateral 
immune and inflammatory effects.           
           Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2). Herpes simplex virus is 
an alpha-herpesvirinae. The HSV-1 infection is often found in orofacial lesions or trigeminal 
ganglia. HSV-2 commonly causes genital herpes. Following primary infection of neurotropic 
herpes simplex virus, the virus develops a latent infection in neuronal nuclei within sensory 
ganglia. Most individuals are asymptomatic after the latent virus remains in the sensory neurons. 
Effective control of herpes virus is mediated by T cells rather than antibodies. High titers of 
herpes-specific antibodies indicate increased viral replication and ineffective cellular immune 
control of virus.  
           In vitro and animal studies showed that immune system responses that involve IFN-γ 
production and HSV specific memory and effector CD8+ T cells play a key role in regulating 
latent herpes virus expression and replication (Freeman, Sheridan, Bonneau & Hendricks, 2007; 
Khanna, Lepisto, Decman & Hendricks, 2004; Huang, Xie & Xu, 2011). Herpes viral latency 
immunity is dependent on HSV-specific CD8+ T cells production of IFN-γ to block HSV-1 
reactivation.  
           Additionally, Freeman and colleagues (2007) in their animal study showed that stress led 
to a significant reduction of HSV-1 specific CD8+ T cells IFN-γ production and decreased the 
number of CD8+ T cells around the nerve ganglion in response to virus reactivation. Latent virus 
reactivation results in virus leakage from latency, anterograde transport to the periphery and 
releases virions at the skin or mucosal surface (Pereira et al., 2003).  
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           Goldmeier and colleagues (2008) suggested that chronic stress could lead to increased 
rates of recurrence of the herpes viral infection. Sainz and colleagues (2001) proposed that stress 
compromises individual cellular immune responses, influences the herpes virus latency-
associated transcript gene (LAT) expression and triggers HSV reactivation. Pereira and 
colleagues (2003) examined the relationship between stress and genital herpes recurrence in 
African American women (N = 34) with the HIV infection during the one year follow-up. They 
found that life stress was highly predictive of genital herpes recurrence after controlling for HIV 
and the relevant behavioral factors of smoking and protease inhibitor usage. Cruess and 
colleagues (2000) reported that HIV positive men had a lower stress score and lower HSV-2 IgG 
titers after ten weeks of stress relaxation intervention.  
           Human herpes virus-6 (HHV-6). HHV-6, a beta-herpesvirinae, is the most common 
cause of childhood diseases - Roseola infantum or Exanthema infection. When first infected with 
HHV-6, the virus replicates in the salivary glands and secretes in saliva. After primary infection, 
the virus remains latent in the lymphocytes and monocytes and is generally asymptomatic in 
healthy individuals. Some cases reported that HHV-6 was associated with central nervous system 
diseases such as seizure, multiple sclerosis or chronic fatigue syndromes. Activated placental 
HHV-6 infection during pregnancy was associated with congenital HHV-6 infection (Caserta et 
al., 2007; Campadelli-Fiume, Mirandola & Menotti, 1999).  
           Cytomegalovirus (CMV). CMV is a beta-herpesvirinae and infection rates are as high as 
90 % in the population. CMV infection, similar to other herpes viruses, can be primary or 
latently reactivated. Transmission of CMV occurs through infected person’s shedding CMV in 
various body fluids, such as blood, urine, semen, breast milk and saliva. Immunocompetent 
women infected with CMV are usually asymptomatic. Symptoms reported are generally vague 
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with fever, myalgia, and malaise. CMV is capable of establishing lifelong latent infection in 
epithelial, endothelial, smooth muscle and connective tissue cells under the control of a healthy 
immune system. Individuals with immunosuppression or organ transplantation are at increased 
risk of CMV infection or reactivation Congenital CMV infection occurs from the placenta to the 
uterus which causes neonates deafness, blindness, mental retardation or death (Johnson & 
Anderson, 2013; Liu et al., 2013).  
           CMV has been indicated as a cell-mediated immune function marker and is linked to 
stress. Stress down- regulated cellular immunity and increased inflammatory cytokines TNF-α 
and IL-6 permit viral reactivation which leads to increased CMV-specific IgG levels (Dowd, 
Aiello, Chyu, Huang & McDade, 2011). Phillips and colleagues (2008) conducted a study of the 
relationship between CMV antibodies titers, depression, and anxiety in older adults.  Results 
found that higher CMV antibody titer was associated with mood disorders. 
           Recently, Liu and colleagues (2013) proposed an epigenetic model of CMV latent 
reactivation. The model suggests that inflammatory cytokines and oxidative stress activate 
transcription factors to bind to the major immediate early promoter (MIEP) gene and induce 
chromatin remodeling to activate viral immediate early gene (IE gene) expression. This IE gene 
does not reactivate and produce infectious viruses in an immunocompetent person, but it does 
reactivate in an immunosuppressed person.   
           Epstein -Barr virus (EBV). EBV is a gamma-herpesvirinae which transmitted through 
oral secretions. The virus remains in the host through life and is carried in a latent form in 
peripheral blood B lymphocytes. EBV expresses its viral genome in newly divided or resting B 
cells to increase the reservoir of latent virus. EBV latent proteins include six nuclear antigens 
(EBNAs 1, 2, 3a, 3b, 3c and LP) and three latent membrane proteins (LMP1, 2A and 2B). 
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EBNA, early antigen (EA), viral capsid antigen (VCA), and latent membrane protein are the 
major virus antigens. EBV EBNA1 is the only viral protein needed to maintain latency in the 
circulation. EBV VCA and anti-EBNA immunoglobulin G (IgG) are always present in the 
seropositive individual (Gesser, 1997; Coskun et al., 2010). 
           After primary infection, EBV remains in its latent form in healthy individuals and 
undergoes sporadic reactivation. Over 90 % of the adult population has EBV latent infection, and 
evidence suggests that EBV reactivation is correlated with stress-induced immune dysregulation 
in response to infection. Immune dysregulation induces EBV replication which leads to 
increased EA and VCA IgG antibody production (Coskun et al., 2010; Christian, 2011).  
           Maternal EBV reactivation causes early fetal death, early delivery, and low birth weight 
infants. Latent EBV infection has been linked to acute lymphoblastic leukemia in infected 
mothers’ offspring (Eskild, Bruu, Stray-Pedersen & Jenum, 2005).  
           Glaser and colleagues (1999) conducted a study to observe the relationship between 
psychological stressor and herpes viral reactivation by measuring HSV-1, HHV-6 and EBV 
VCA IgG antibodies titer in military academy students during and after a six-week training 
period. Significant elevation of EBV antibody titers was associated with a diversity of 
psychological stressors. This study provided the base research model in stress and latent herpes 
viral reactivation. 
Neuroimmune Pathways and Depression 
           Research has shown that depression is often associated with imbalance in monoamine 
neurotransmitters  metabolism (Sperner-Unterweger, Kohl & Fuchs, 2012; Felger et al., 2012; 
Haroon, Raison & Miller, 2012; Littrell, 2012; Capuron & Miller, 2011; Capuron et al., 2011; 
McTavish, Mannie, Harmer & Cowen, 2005; Scrandis et al., 2008, Widner, Laich, Sperner-
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Unterweger, Ledochowski & Fuchs, 2002). Inflammatory factors such as cytokines and reactive 
oxygen species (ROS) drive biogenic amines in such a way that dopamine, melatonin and 
serotonin are decreased, and these neurotransmitters all play important roles in the 
pathophysiology of depression. Figure 2 shows the biogenic amine pathways affected by 
inflammation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Biogenic amine pathways affected by inflammation 
MØ: macrophage, DC: dendritic cells, PAH: phenylalanine-hydroxylase, TPH: tryptophan hydroxylase, GTP-CH1: 
guanosine-triphosphate-cyclohydrolase-1, IDO: indoleamine-2, 3-dioxygenase, TDO: tryptophan-2, 3-dioxygenase, 
BH4: tetrahydrobiopterin, NMDA: N-methyl-D-aspartate 
 
           In pregnancy, while type 1 adaptive immunity is somewhat suppressed, the innate 
immune system is highly activated. The pathway may thus be altered in pregnancy in the 
following ways: (1) high levels of corticosteroids activate  tryptophan-2, 3-dioxygenase (TDO), 
which is the first step in the conversion of tryptophan to kynurenine, (2) inflammatory cytokines 
induce IDO catabolism of tryptophan into kynurenine; both TDO and  IDO activation reduces 
serotonin synthesis, (3) inflammatory cytokines and reactive oxygen species (ROS) decrease  
5,6,7,8-tetrahydrobiopterin (BH4) and increase neopterin levels through activation of GTP-CH1 
activity, (4) reduction of BH4 (hydroxylase cofactor) leads to impairment  in the conversion of 
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phenylalanine to tyrosine, tyrosine to dopamine, dopamine to norepinephrine, epinephrine and 
tryptophan to serotonin. These relationships are depicted in Figure 2. Capuron and colleagues 
(2011) reported that serotonin and dopamine metabolic pathways were associated with 
depressive symptoms in the elderly. Currently no studies were found that examined IDO /TDO 
and GTP-CH1 pathways in prenatal depression. 
           Neopterin, nitrite and BH4. Neopterin is secreted by monocytes or macrophages upon 
activation by IFN-γ from T cells and is augmented by ROS, nitrite is the end product of nitric 
oxide (NO) and plays a role in immune process and metabolic regulation and BH4 is a cofactor 
of phenylalanine-, tyrosine- and tryptophan-5-hydroxylase and NO synthases. The function of 
neopterin is not well understood, but it is believed to possibly induce nuclear factor- kappa B 
(NF- k B) expression and trigger apoptosis. Several studies have measured neopterin, together 
with tryptophan and kynurenine level, to assess the relationship between immune activation and 
depression (Widner, Laich, Sperner-Unterweger, Ledochowski & Fuchs, 2002; Berdowska & 
Zwirska-Korczala 2001; von Versen-Hoeynelk et al., 2009; Murr, Widner, Wirleitner & Fuchs, 
2002). 
           Tryptophan, IDO and kynurenine. Tryptophan is important for serotonin and melatonin 
biosynthesis. Tryptophan catabolizes through two pathways. One is through tryptophan 5-
hydroxylase decarboxylation to form serotonin. The other pathway is the kynurenine pathway 
through TDO and IDO, in which tryptophan is catabolized to kynurenine, leading to degradation 
into the 3-hydroxykynurenine, quinolinic acid, and kynurenic acid pathway. Kynurenic acid 
crosses the blood-brain barrier and acts on the glutaminergic receptor, N-methyl-D-aspartate 
(NMDA), which is associated with the functions of cognitive memory, learning, and attention 
(Haroon, Raison & Miller, 2012;  Dantzer, O’Connor, Freund, Johnson & Kelley, 2008; 
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Schrocksnadel, Wirleitner, Winkler & Fucs, 2006; Widner et al., 2002; Kurz et al., 2012; 
Capuron et al., 2011; Sublette & Postolache, 2012; Miller, Maletic & Raison, 2009). 
           Depressive symptoms have been linked to cytokines IFN-γ and IL-2 induced IDO 
activation in recent studies. O’Connor and colleagues (2009) investigated relationships between 
depressive symptoms, IDO activation, and tryptophan depletion in an animal study by injecting 
Bacilli Calmette-Guerin (BCG) in mice. In 2012, Elovainio and colleagues studied the 
relationship between IDO activation and depressive symptoms in a large population of healthy 
young Finns. The study found that IDO activity was a predictor for future depression 
development in women.  
           In addition to the inflammatory pathways described above, pregnant women have lower 
tryptophan due to the placenta producing large amounts of IDO to achieve immune tolerance for 
the fetus. Tryptophan is an essential amino acid required by T cells, and activation of IDO 
starves T cells that could potentially react to fetal antigens; however, decreased tryptophan 
would also reduce serotonin synthesis and potentially increase the risk of depression (Munn et 
al., 1998; Kohl et al., 2005). IDO activity can be assessed by ratio of kynurenine to tryptophan. 
           Two studies provide evidence of IDO activation and low tryptophan during normal 
pregnancy (Schrocksnadel et al., 2003; Alegra, Diaz-Lagares & Gonzalwz, 2008). Additionally, 
Scrandis and colleagues (2008) conducted a small sample (N = 27) longitudinal study to examine 
CRP elevation, IDO activation, and tryptophan depletion in women with prenatal depressive 
symptoms. They concluded that CRP and IL-6 elevation were correlated with IDO pathway 
tryptophan depletion and kynurenine elevation which were associated with prenatal and 
postpartum depression. Research is needed to examine the relationship between IDO activation 
and depression in pregnant women. 
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           Phenylalanine and tyrosine. BH4 is an important cofactor of several hydroxylases, 
including phenylalanine-hydroxylase (PAH). Phenylalanine is catalyzed by PAH to produce 
tyrosine, a precursor for dopamine biosynthesis (Sperner-Unterweger, Kohl & Fuchs, 2012; 
Capuron et al., 2011; Ploder, Neurauter, Spittler, Schrocksnadel, Roth & Fuchs, 2007; McTavish, 
Mannie, Harmer & Cowen, 2005; Leyto et al., 1999). An increase in either serum phenylalanine 
concentration or phenylalanine to tyrosine ratio (Phe /Tyr) may be due to decreased PAH 
activity, resulting from immune activation and inflammation that inhibits BH4 activity. There is 
evidence of increased phenylalanine levels in the blood correlated to trauma, sepsis, viral 
infection, and cancer (Ploder et al., 2005; Neurauter et al., 2008; Zangerle et al., 2010), or 
tyrosine dietary depletion (McTavish, Mannie, Harmer & Cowen, 2005; Parker & Brotchie, 
2011). Capuron and colleagues (2011) found BH4 deficiency and increased blood neopterin in 
depression and schizophrenia patients.  
Herpes Viruses, IDO Activation and Depression 
           Effective control of herpes virus is mediated by cytotoxic T cells rather than antibodies. 
High titers of herpes-specific antibodies are an indication of increased viral replication and 
ineffective cellular immune control over the virus. Recent in vitro and animal studies by Huang 
(2011), Freeman (2007), and Khanna (2004) showed that IFN-γ production and HSV specific 
memory and effector CD8+ T cells play a key role in regulating latent herpes viral expression 
and replication. Immune activation of IDO decreases tryptophan concentration, slowing down 
protein synthesis to inhibit pathogens or malignant cell growth. Chronic infection leads to 
increased IFN levels which affect serotonin synthesis and glutamate and quinolinic acid levels 
causing depression (Haroon et al., 2012; Schrocksnadel, Wirleitner, Winkler & Fuchs, 2006).  
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           Korf and colleagues (2002) referred to studies on depression and herpes viral reactivation 
as consequence of activation of the inflammatory response system which is mediated by the 
limbic system. Limited research has shown the connection between IDO activation, herpes virus 
and depression; however, Bellman-Weiler and colleagues (2008) showed fatigue symptoms in 
chronic EBV infection, HIV, and cancer patients are associated with herpes viral titers (Bellman-
Weiler et al., 2008; Fagundes et al., 2012). This study reported that patients with detectable EBV 
DNA and IgA titers had higher neopterin, IFN-γ mediated IDO activity and lower tryptophan 
concentration, which correlated to fatigue symptoms. 
           Adams and colleagues (2004) reported that IFN-γ and TNF-α induced IDO activity, which 
inhibited HSV replication. Conflicting data reported by Divanovic and colleagues (2012) showed 
that there was no evident role of IDO in HSV-1 infection. Whether the low level of tryptophan is 
due to IDO activation or not is not fully understood. The new 5-HT (5-hydroxytrptamine) 
hypothesis of depression, which states that cellular immune activation induces IDO activation 
which disrupts tryptophan metabolism to affect serotonin synthesis, is currently under 
examination (Maes, Leonard, Myint, Kubera & Verkerk, 2011; Sublette et al., 2011).  
Chapter Summary 
          Pregnancy is a vulnerable time for women due to physiological and psychosocial changes. 
Research shows that there is a positive relationship between prenatal psychosocial stress and 
depression. A growing number of studies support the hypothesis that elevation of pro-
inflammatory cytokines is associated with depressive symptoms in pregnant women; however, 
there are still some conflicting results about the relationship between depressive symptoms and 
inflammatory cytokines in pregnant women.  
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          There is very little known about the role of inflammation or pregnancy induced IDO and 
GTP-CH1 activation resulting in alternated biogenic amines in prenatal depression. Further 
research is needed regarding psychosocial stress, latent viral reactivation, and biogenic amines 
metabolites in prenatal depression or depressive symptoms.  
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CHAPTER THREE 
 
METHODS 
           This chapter focused on the study design, sample, and setting. The measures used in the 
secondary data were analyzed to measure EBV VCA IgG titer. 
Research Design, Sample and Setting  
           Parent R01 study method. This exploratory study consists of a secondary analysis of the 
Perceived Stress Scale (PSS), the Profile of Mood States (POMS), biogenic amines, herpes viral 
titers, and EBV antibody IgG titer from stored plasma samples from pregnant women enrolled in 
a funded study (R01NR05000). The study participants were recruited from University of South 
Florida (USF), Health Department and Tampa General Hospital Obstetrical and Gynecology 
practice sites. The target population was focused on pregnant women between the ages of 18 and 
45 years at 16 to 25 gestational weeks. A total sample of 631 pregnant women was recruited in 
this original study from 2007-2011. Data from a sample of 380 pregnant women was available to 
analyze in the current study.  
           Inclusion criteria for the study were pregnant women between 18 to 45 years and all 
minority groups. Exclusion criteria were women with HIV/AIDS, those with immune disease, 
people taking immune altering medications, participants who were in vitro fertilized, illegal 
substance abusers, and extremely thin women. This study was feasible because of the large 
sample size and availability of a well-established bio-behavioral laboratory to perform assays at 
the USF College of Nursing.  
 
26 
 
Measures 
           Demographic information, two psychological questionnaires (PSS and POMS) and 15 mL 
of blood were collected from each participant during the prenatal time of enrollment between 16 
to 25 weeks of gestation. This plasma was analyzed for a panel of herpes viral titers: HSV-1, 
HSV-2, HHV-6, CMV, thyroid peroxidase antibody (TPO) and Toxoplasma gondii antibody in 
the parent study in Dr. Robert Yolken’s laboratory at Johns Hopkins School of Medicine. In 
addition a panel of biogenic amines: nitrite, tryptophan, kynurenine, phenylalanine, and tyrosine 
were measured by high-performance liquid chromatography (HPLC) in Dr. Dietmar Fuchs’s 
laboratory at the University of Salzburg, Austria. Kynurenine /tryptophan (KYN /TRP) ratios 
phenylalanine /tyrosine (Phe/Tyr) ratios were calculated and neopterin was measured by 
enzyme-linked immunosorbent assay (ELISA). The investigator added to the viral panel by 
assaying EBV antibody IgG titer by ELISA. The variables in this study are presented in Table 1. 
           Demographic data. Baseline data, which were collected at the time of recruitment, 
included age, ethnicity, years of education, income, gravidity, the presence of any chronic or 
acute health problems, current medications, and height and weight at the time of enrollment to 
calculate body mass index (BMI).   
           Perceived stress scale (PSS). The PSS is a 14-item instrument to evaluate cognitions and 
emotions related to perceived general stress that an individual felt or thought of as stressful in the 
week preceding the measurement. Participants completed the PSS at the time of enrollment in 16 
to 25 gestational weeks. The PSS-14 uses a 5-point Likert-type summated rating scale response 
format (0 = never to 4 = very often) and has a range of 0 to 56.  The PSS consistently has had 
Cronbach’s alphas between .84 and .86 (Cohen, Kamarck & Mermelstein, 1983). The PSS also 
has short-term test-retest reliability (.85) as well as constructed validity. The parent R01 pregnant 
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and postpartum thyroid peroxidase antibody study had PSS Cronbach’s alpha (α) = .84 (Groer & 
Vaughn, 2013). 
Table 1  
Table of Variables from Parent R01 and Current Study 
Variable Measure- Instrument 
 
Measurement 
R01 Study   
     Demographics Age, ethnicity, BMI, Number of children, 
Number of pregnancy 
Self-report 
   
     Stress Perceived Stress Scale (PSS) Self-report 
     Depressive Symptoms Profile of Mood States-Depression Scale Self-report 
     Fatigue Symptoms Profile of Mood States-Fatigue Scale Self-report 
      
     Herpes Virus Titers  
 
HSV-1, HSV-2, HHV-6, CMV 
 
ELISA 
   
     Biogenic Amines Tryptophan, Kynurenine, 
Kynurenine/Tryptophan ratio, 
Phenylalanine, Tyrosine, 
Phenylalanine/Tyrosine ratio, 
Nitrite 
HPLC 
 
 
 
ELISA 
    Inflammatory Protein                            Neopterin ELISA 
    Other Biomarker Toxoplasma gondii IgG ELISA 
 TPO Antibody ELISA 
Current Study   
   
    Herpes Virus Titers    EBV VCA-IgG ELISA 
   
Note: ELISA: Enzyme-linked immunosorbent assay, HPLC: High-performance liquid chromatography, 
HSV: Herpes simplex virus, HHV-6: Human herpes virus-6, CMV: Cytomegalovirus, TPO: Thyroid 
peroxidase, EBV: Epstein-Barr virus, VCA: Viral capsid antigen 
           Profile of mood states (POMS). Participants completed the POMS (McNair, Lorr & 
Droppleman, 1992) at the time of enrollment. The instrument provided a multi-dimensional 
assessment of mood to measure how the participant had felt over the week prior to enrollment. 
The POMS is a 65-item, 5-point Likert-type scale (0 = not at all to 4 = extremely) and has a total 
mood disturbance score and 6 subscales: depression-dejection (15 items, score range 0 -60), 
tension-anxiety (9 items, score range 0 -36), confusion-bewilderment (7 items, score range 0- 
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28), fatigue-inertia (7 items, score range 0 -28), anger-hostility (12 items, score range 0 - 48), 
and vigor-activity (8 items, score range 0 -28).  
           POMS-Fatigue (POMS-F) score is determined by calculation the scores for worn out, 
listless, fatigued, exhausted, sluggish, weary and bushed. The POMS depression-dejection score 
(POMS-D) is determined by calculation the scores for unhappy, sorry for things done, sad, blue, 
hopeless, unworthy, discouraged, lonely, miserable, gloomy, desperate, helpless, worthless, 
terrified and guilty. The POMS-F scores range from 0 – 28 and POMS-D scores range from 0 to 
60, with higher scores suggesting increased mood disturbance during the past week. 
           Many studies reported POMS has good internal consistency, reliability, and moderate test-
retest reliability (Griffith et al., 2005). POMS scores have internal consistency from .87 to .92 
and test-retest reliabilities ranging from .65 to .74 (Cruess et al., 2000). The parent R01 study 
pregnant and postpartum thyroid peroxidase antibody study had POMS-D Cronbach’s alpha  
(α) = .91 (Groer & Vaughn, 2013). The POMS-D cut-off score for clinical depression screening 
is 20. Participants with a POMS-D score over 20 were referred to healthcare providers for further 
evaluation of depressive symptoms. 
           Blood collection and processing. When participants between 16 to 25 weeks of 
pregnancy enrolled, their peripheral blood samples (15 mL) were collected by antecubital 
venipuncture, kept cold, and brought to the bio-behavioral laboratory within two hours. The 
blood was centrifuged at 3800 rpm for 25 minutes at 4°C. The plasma supernatants were 
aliquotted and stored at -80° C. After samples were collected, they were analyzed by herpes viral 
IgG immunoassay and biogenic amines chromatography assays. 
           Herpes viral IgG immunoassay. HSV-1, HSV-2, HHV-6, and CMV IgG and Toxoplasma 
gondii IgG serology performed by solid-phase enzyme immunoassay method at The Stanley 
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Virology laboratory at Johns Hopkins University by Dr. Robert Yolken. EBV antibody IgG 
serology followed by manufacturer (ALPCO) protocol and was performed at the bio-behavioral 
laboratory at College of Nursing, University of South Florida.  
           Biogenic amines chromatography. Plasma tryptophan (μmol/L), kynurenine (μmol/L), 
phenylalanine (μmol/L) and tyrosine (μmol/L) were analyzed by high-performance liquid 
chromatography (Winder, Werner, Schennach, Wachter & Fuchs, 1999) by Dr. Dietmar Fuchs at 
the University of Innsbruck, Austria. The kynurenine to tryptophan and phenylalanine to tyrosine 
ratios were calculated by this method. Neopterin (μmol/L) and nitrite (μmol/L) were measured 
by ELISA (BRAHMS, Hennigsdorf, Germany) with detection limits of 2 nmol/L. 
Procedures 
           The parent study was approved clinic sites and the University of South Florida (USF) 
Institutional Review Board (IRB) prior to the collection of data. Pregnant women between 16 to 
25 weeks’ gestation who met inclusion criteria were recruited from USF’s Obstetrical and 
Gynecology clinic, Tampa General Hospital Genesis clinic and the Health Department in 
Tampa.  
           The participants were informed that there was a possibility that the researchers would 
discover thyroid problems during the course of the study and that the participants would be 
referred back to their providers for diagnosis and treatment. They gave permission for the 
researchers to contact their health providers if any significant health problems were to be 
discovered during the course of the study. This would include both physical and mental health 
problems. All pregnant women were assured of the confidentiality of all data. Participants were 
provided time to read the consent document, discuss the information, and ask questions. 
Participants then signed the informed consent for the study.  
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           The research data were obtained from demographic data, psychosocial self-report 
questionnaires, and blood samples (12-15 mL) in clinic offices during one of the participant’s 
prenatal routine appointment. The blood was sent to the bio-behavior laboratory at College of 
Nursing for analysis related to the study. Plasma samples were stored in laboratory freezers at  
-80° C. Biohazard procedures were followed in the performance of the assay and the disposal of 
wastes.  
           EBV VCA IgG immunoassay. EBV viral capsid antigen (VCA) IgG ELISA assay 
(ALPCO, 20-EVGHU-E01, 96 wells commercial kit) that measures EBV VCA IgG was used to 
determine EBV titer and all analyses were performed by the PhD candidate. All ALPCO 
reagents, ELISA plates and plasma samples were allowed to reach room temperature before use 
on the day of assay. 
           First, the wash solution was warmed to 37° C and crystals were completely dissolved 
before use. Diluted wash solution was prepared by adding 30 mL buffer solution to 570 mL fresh 
distilled water. Plasma aliquots kept at -80° C were thawed at room temperature and centrifuged 
(5430 R eppendorf) 5000 revolutions per minutes (rpm) for 5 minutes before the assay. Plasma 
samples were diluted 1:101 with a sample diluent buffer according to the protocol provided by 
manufacture, mixed well by vortex (Fixed Speed Mini Vortexer, Fish Scientific) and left at 15 
minutes before dispensing to 96 wells. 
           Each ELISA plate was run using duplicate wells for blank background, three controls 
(negative control, cut-off control, and positive control), and diluted samples. Wells were covered 
with foil after 100 μL were dispensed into each well and incubated for 60 minutes at 37° C 
incubator. Following incubation, a plate washer (Microplate washer, Finstruments) was used to 
rinse the wells five times with diluted wash solution.  
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           After rinsing the plate, 100 μL Enzyme Conjugate Solution were dispensed into each well 
except blank control wells, and then the plate was incubated in the dark, at room temperature for 
30 minutes. Following incubation, a plate washer was used to rinse the wells five times with 
diluted wash solution. Residual droplets were removed and then 100 μL of Substrate Solution 
were added into all wells. The plate was incubated in the dark, at room temperature for exactly 
15 minutes. After incubation, Stop Solution was added to each well to stop enzymatic reaction. 
After adding the Stop Solution, the plate was placed into microtiter plate reader (Thermo 
Labsystems Multiskan MCC/340, Fisher Scientific) and read at the optical density (OD) of 
450/620 nm. 
           EBV IgG titers calculation. EBV IgG titer was calculated by the mean absorbance 
values at the OD 450 nm of all duplicates wells minus blank background. A final result in units 
(DU) was calculated by sample (mean) absorbance value multiplied by 10 and divided by the cut 
off control (CO). 
           Storage of study materials. The data were coded and remained confidential. Study forms 
were stored in a locked file cabinet at the University, and only the Principle Investigator (PI) and 
study personnel have access to these forms. Electronic data files were de-identified, and files 
were password protected. The proposed procedures of this secondary analysis were reviewed by 
the University IRB prior to the initiation of the study.  This candidate’s addendum to the current 
research protocol has been approved by University of South Florida IRB (Ame3_104998) on 
3/21/2013 (See Appendix D). The original forms would not be accessed for the purposes of this 
secondary data analysis. De-identified study data files were obtained from R01 study Principle 
Investigator, Dr. Groer.  
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Data Analysis Plan 
           Preliminary data analyses.  Using Microsoft Excel software version 2010 and Statistical 
Package for Social Sciences (SPSS) computer software version 21, data cleaning and data 
processing were performed to detect corrupt or inaccurate data.  
           Univariate data analysis in this study included descriptive statistics, means and standard 
deviations of all the variables with perceived stress scores, depression scores, biogenic amines, 
and herpes viral IgG titers. Histograms, scatterplots, and line graphs were used to examine the 
data. All of the data were analyzed for normality, outliers, and missing data. Common logarithm 
(log10) transformations were performed if needed for negative skewness and outliers were 
checked. Covariates were analyzed included age, race, number of children, BMI, Toxoplasma 
gondii antibody and thyroid peroxidase antibody (TPO) titers.  
           Bivariate data analysis in this study included: (1) Chi-square tests for two categorical 
variables, (2) independent sample t-tests to compare two different groups mean scores, and (3) 
Pearson’s product moment correlations to assess the relations between continuous variables and 
depressive symptoms scores.  
           Correlations among variables were calculated using Pearson’s product moment correlation 
coefficients (r ) to evaluate the association between stress, depression scores, POMS other 
subscales, tryptophan, kynurenine, phenylalanine, tyrosine, neopterin, nitrite, herpes viral IgG 
titers (HSV-1, HSV-2, HHV-6, CMV, EBV) and also ratios of  kynurenine to tryptophan and 
phenylalanine to tyrosine. The correlation coefficient is a measure of linear association between 
two variables. A correlation coefficient value is between -1 and +1. A value of +1 indicates that 
two variables are perfectly related, a value of -1 indicates a perfectly negative linear relationship, 
and 0 indicates that there is no linear relationship between two variables (Hays, 1994).  
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           Multivariate data analysis in this study included one-way analysis of variance (ANOVA) 
to compare mean scores of  two or more groups and multiple regression analysis to explore the 
relationship between one continuous dependent variable (e.g. perceived stress, depressive 
symptoms) and a number of continuous independent variables.  
           In multiple regression analysis, assuming a relationship between the independent and 
dependent variable, the probability of making a type I error to falsely reject a correct model 
is .05 at a statistical power level of .8. The required sample size for regression is N ≥ 50+8 m  
(m is the number of independent variables) for testing the multiple regression and N ≥ 104+ m 
for testing individual predictors (Tabachnick & Fidell, 2007). Thus, the sample size in this study  
(N = 380) was sufficient for analysis. 
           The goal of multiple regression is to understand each predictors (independent variable) 
relationships to prenatal depressive symptoms. The suppression effects among predictors were 
examined to limit irrelevant elements between predictors and criterion (Beckstead, 2012).  
           Regression analysis is a statistical technique used for studying linear relationship, 
predicting the value of one dependent variable from the value of one independent variable. 
Assumptions for regression analysis include: the variables have normal distribution (normality), 
the predictors are linearly independent (linearity), the errors are uncorrelated (homoscedasticity), 
and the error is independent (Tabachnick & Fidell, 2007).  
           Steps involved in regression analysis include: (1) state the research hypothesis and null 
hypothesis, (2) assess normality on each variable separately, (3) assess the linear relationship of 
the  independent variable and the dependent variable (correlation coefficient), (4) estimates the 
regression equation from data, (5) estimates and examine appropriate measures of association 
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and test of statistical significance for each coefficient and for the equation, (6) accept or reject 
the null hypothesis, (7) accept or reject research hypothesis. 
           Analyses to address the hypothesis. Multiple regressions were conducted to evaluate the 
influence of variables (perceived stress, herpes viral titers) on the dependent variable (depressive 
symptoms) and metabolites of the IDO and GTP-CH1 pathways while controlling for covariate 
variables. To address the three hypotheses, following data analysis methods were used: 
           Hypothesis 1. There is a significant positive relationship between stress and depressive 
symptoms in pregnant women. The tentative hypothesis is that higher levels of stress increased 
severity of depressive symptom in pregnant women. Regression analysis was used to explore the 
relationship between stress and dysphoric moods such as depressive or fatigue symptoms during 
pregnancy. The independent variable was perceived stress and the dependent variable was 
depressive symptoms. The regression is given by: (Y’1) = a +b1 (x1). Y’1 (POMS-D) can be 
expressed in terms of a constant (a) and a slope (b1) times the (x1, stress) variable. The goal of this 
regression was to assess the value and significance of coefficient values, controlling for 
demographics, BMI, and number of children. 
           Hypothesis 2. There are significant positive relationships among herpes viral titers, stress 
and depressive symptoms in pregnant women. The tentative hypothesis is that the severity of 
depressive symptoms increases as the level of stress increases, and this positive relationship is 
partially mediated by herpes viral titers in pregnant women. 
           The independent variable was perceived stress. The dependent variable was depressive 
symptoms (POMS-D), and herpes viral titers (HSV-1, HSV-2, HHV-6, CMV, and EBV) are the 
mediator /intervening variable (Table 2). Multiple regression analyses were used to explore the 
relationship between stress, depression and herpes viral titers:  
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Depression (Y2.1) = a +b1 (stress) + b2 (herpes viral titers) 
           Mediation analysis. The three regression paths for testing mediational effect were (Baron 
& Kenny, 1986): (1) regressing the dependent variable (depressive symptoms) on the 
independent variable (perceived stress), (2) regressing the mediator (herpes viral titers) on the 
independent variable (perceived stress), and (3) regressing the dependent variable (depressive 
symptoms) on both the mediator (herpes viral titers) and the independent variable (perceived 
stress). 
 
Table 2  
Data Analysis 
 
Hypothesis Regression 
  
1. Stress Depression 
 
2. StressHerpes viral titers Depression 
 
3. StressHerpes viral titers  KYN /TRP ratio Depression     
  
Stress NeopterinPhe /Tyr ratioDepression 
 
Note. KYN /TRP: kynurenine /tryptophan, Phe /Tyr: Phenylalanine /Tyrosine 
 
           Hypothesis 3. The kynurenine /tryptophan ratios (KYN /TRP) and phenylalanine /tyrosine 
ratios (Phe /Tyr), and neopterin levels are increased positively related to herpes viral titers in 
depressed pregnant women. Multiple regression analysis was used to explore the relationship 
between stress, neuroimmune biogenic amines, herpes viral titers, and depression (Table 2).  
           For stress, depression, herpes viral titer and KYN /TRP ratio: 
Depression (Y3.1) = a +b1 (stress) + b2 (herpes viral titers) +b3 (KYN /TRP) 
           For stress, depression, herpes viral titer and level of neopterin: 
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Depression (Y3.6) = a +b1 (stress) + b2 (herpes viral titers) +b3 (KYN /TRP) +b4 (neopterin) 
           For stress, depression, herpes viral titer, and Phe /Tyr ratio: 
Depression (Y3.11) = a +b1 (stress) + b2 (herpes viral titers) +b3 (KYN /TRP) +b4 (neopterin) +  
                                 b5 (Phe /Tyr) 
Figure 3 summary hypothesized model of prenatal depression in the current study. 
 
 
 
 
 
 
 
 
 
 
 
   Figure 3. Hypothesized relationships in prenatal stress, herpes viral titers leading to biogenic 
   amines alteration in prenatal depressive symptoms.  
                     
Chapter Summary 
           Influence of Lactation on Postpartum Stress and Immunity study was the foundation for 
this study on relationships of prenatal stress, depression and herpes viral titers. It provided 
baseline data from women collected at 16 to 25 gestational weeks that was used for secondary 
data analysis. This original data set includes PSS, POMS, neuroimmune biogenic amines; HSV-
1, HSV-2, HHV-6, CMV herpes viral titers. Additional EBV viral titers were measured in stored 
plasma samples. The aim of this study was to examine relationships among stress, herpes viral 
reactivation, the IDO activation pathway, and depression.  
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CHAPTER FOUR 
 
RESULTS 
 
Preliminary Analyses 
           Screening and cleaning data.  Total samples of 640 pregnant women were in the 
prenatal R01 electronic SPSS data file. To avoid the risk of affecting statistical power and 
increasing chance of making Type I or Type II errors, incomplete data sets were not included in 
the final analysis. These included variables such as education, income, marital status, work 
status, smoking, and biogenic amines and herpes viral titers which were available on 431 
women. After filtering out missing data, a full set total of 380 samples were included in this data 
analysis. The variables in this study are: demographic data (age, race, gravidity, number of 
children, BMI); self- report questionnaires (Perceived Stress Scale, Profile of Mood States); 
herpes viral antibody IgG titers (HSV-1, HSV-2, HHV-6, CMV); biogenic amines (tryptophan, 
kynurenine, kynurenine /tryptophan ratio (KYN /TRP), phenylalanine, tyrosine, phenylalanine 
/tyrosine ratio (Phe /Tyr), nitrite, and neopterin), and potential covariate variables (thyroid 
peroxidase antibody, Toxoplasma gondii IgG titer). All EBV viral capsid antigen (VCA) 
antibody IgG titers were performed by the PhD candidate and added in this study. A total sample 
N = 219 EBV VCA IgG titer was added to the data set.    
           The data screening processes were conducted in two steps: (1) checking each variable for 
scores that are out of range by checking minimum and maximum values, mean, standard 
deviation, and frequencies, (2) finding and correcting the error in the data file. 
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            Description of the sample. Variable descriptive statistics including mean, standard 
deviation, range of scores, skewness, kurtosis and normality were assessed. The participants 
were in the early second trimester, averaging 19 weeks of pregnancy. As shown in Table 3, 
participants’ ages ranged from 17 to 45 years. The most common race reported was Caucasian. 
Approximately 23.2 % of participants identified themselves as African American /Black and  
22.9 % as Hispanic. The number of children reported by participants ranged from 0 to 6. Nearly 
45.5 % of participants have no child at home, 31.3 % have one child, and 15.5 % have two 
children at home.   
           Participants pre-pregnancy body mass index (Pre-BMI) was calculated using self- 
reported pre-pregnancy weight and height and range from 17.2 to 58.3 (Mean = 27.01, SD = 
6.80). Upon enrollment in this study, participants BMI ranged from 18.7 to 60 (Mean = 28.85, 
SD = 6.48). Pre-pregnancy BMI was highly correlated with BMI upon enrollment (r = .933, 
p= .000). The accuracy of BMI was affected by pregnancy related weight gain, so pre-pregnancy 
BMI was used in this statistical analysis. Total of 375 BMI data were available in this study.  
           The Perceived Stress Scale (PSS) data from participants responses were on 1 to 5 Likert-
type scale (1 = never, 2 = almost never, 3 = sometimes, 4 = fairly often, 5 = very often). The 
scores on the seven positive questionnaires were reversed and all the questionnaires were 
summed to calculate a total score in SPSS data file. The PSS score in this study had a range of 2 
to 45 (Mean = 22.04, SD = 7.13). Cronbach’s alpha (α) coefficient in this study was .85. 
           Participants’ responses from the 65 -items Profile of Mood State (POMS) scale were 
collected and then each subscale was calculated. The POMS depression-dejection subscale score  
(POMS-D) is a 15- item scale which ranged from 0 to 60. The POMS-D in this study had a range 
from 0 to 49 (Mean = 5.72, SD = 8.51), Cronbach’s alpha coefficient was .91. African American 
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women had higher depression scores than Caucasian or Hispanic women (Table 3). Twenty-five 
participants (6.6 %) POMS-D scores were over 20 which indicated clinical depression and they 
were referred to their provider for further depression evaluation and treatment. POMS fatigue-
inertia (POMS-F) is a 7-item scale which ranged from 0 to 28. The POMS-F in this study had a 
range from 0 to 25 (Mean = 8.04, SD = 5.38), Cronbach’s alpha coefficient was .87. 
Table 3  
Sample Demographic Characteristics and Psychosocial Measures (N=380) 
 
Variable 
 
N           % Min-
Maximum 
  M SD  POMS-D Score 
  M              SD 
Age      17-45 28.22 5.99   
Race        
   Caucasian 179 47.1    4.05   6.44 
   African America   88 23.2    7.85 11.62 
   Hispanic   87 22.9    6.90   7.89 
   Asian   11   2.9    5.09   7.40 
   Native America     2     0.5    0.00   0.00 
   Other   13   3.4    8.69   9.89 
Number of Children 
    0 
    1 
    2 
    3 
    4 
    5 
    6 
 
173  
119  
  59  
  12    
  11    
    3      
    3      
 
45.5 
31.3 
15.5 
  3.2 
  2.9 
  0.8 
  0.8 
    0 - 6  0.92 1.14   
BMI   17.20-58.30 26.98  6.85   
Perceive Stress Scale  (PSS)    2-45 22.04  7.13   
POMS-Depression     0-49   5.72 8.51 
POMS-Fatigue     0-25   8.04 5.38 
        
Note. BMI: Body mass index, POMS: Profile of Mood States, M: Mean, SD: Standard deviation   
Cronbach’s α = PSS (.85), POMS-D (.91), POMS-F (.87)  
 
           Biological variables. Raw data of biological variables including herpes viral titers and 
biogenic amines are summarized in Table 4. The serological herpes viral titers (HSV-1, HSV-2, 
HHV-6, and CMV) cut-off point was taken from the Stanley Virology Laboratory of Johns 
Hopkins University headed by Dr. Robert Yolken (Dickerson et al., 2003; Groer et al., 2011) for 
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quantitative analysis. The cut-off point for seropositivity to HSV-1, HSV-2, and CMV was 1 and 
for HHV-6 was 6. The EBV VCA IgG enzyme-linked immunosorbent assay (ELISA) was 
performed at College of Nursing, University of South Florida. EBV IgG was measured by optical 
density ratio units and calculated according to manufacturer (ALPCO). The cut-off point for 
EBV was 10 and intra-assay coefficients of variation were less than 10 % (Table 5). The above 
threshold antibody titers (seropositive) to different herpes viruses were analyzed as a continuous 
variable when relationships among stress, depression, and biogenic amine pathways were 
examined.  
 
Table 4 
Biological Variables (N =380) 
 
Variable Min-Maximum    M    SD 
 
    
Herpes Viral Titers    
   Herpes Simplex Virus type 1 (HSV-1)   0.07-   7.76   2.97   2.62 
   Herpes Simplex Virus type 2 (HSV-2)   0.05- 13.60   1.27   2.53 
   Human Herpes Virus-6 (HHV-6)    0.30- 29.53 11.09   6.17 
   Cytomegalovirus (CMV)    0.13- 10.52   2.73   2.54 
   Epstein-Barr Virus (EBVǂ)   3.62- 39.25 23.24   8.75 
    
Biogenic Amine    
   Neopterin (Neo)   2.93-  18.69   5.83   2.05 
   Nitrite (Nitr)   2.00-  87.00 19.13 13.85 
   Tryptophan (TRP)   8.00-122.00 62.28 14.72 
   Kynurenine (KYN)   0.00-    5.00   1.90   0.74 
   Kynurenine/ Tryptophan ratio (KYN /TRP)    8.00-  72.00 31.10 11.50 
   Phenylalanine (Phe) 18.00-132.00 52.34 15.08 
   Tyrosine (Tyr)   5.00-130.00 43.13 16.98 
   Phenylalanine /Tyrosine ratio (Phe /Tyr)    0.00-    9.00   1.09   0.49 
    
Other Potential Covariate    
   Toxoplasma gondii (toxo)   0.90-    4.17    0.45    0.88 
   Thyroid peroxidase antibody (TPO)   0.00-  12.27    0.11    0.68 
    
Note. EBVǂ N = 219, M: Mean, SD: Standard deviation 
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Table 5  
Variables Threshold Cut-off point (N =380) 
 
Variable Cut-off 
Point 
Below Cut-off  Point 
 
   N                % 
Over Cut-off  Point 
 
  N                % 
      
Profile of Mood States- Depression  20 355 93.4   25      6.6 
Herpes simplex virus type 1   1 163  42.2 217  57.8 
Herpes simplex virus type 2   1 297  78.0   83  22.0 
Human herpes virus-6    6   90  23.8 290  76.2 
Cytomegalovirus    1 158  39.9 222  60.1 
Epstein-Barr virus (EBVǂ) 10   21      9.3 198  90.7 
      
Note. EBVǂ N = 219    
 
           Bivariate data analysis (Pearson correlation) was conducted to assess and explore the 
variables relationships among dysphoric moods (POMS-depression, fatigue, anxiety, anger, 
vigor, and confusion) and the significance of coefficient values (Table 6). When EBV IgG titers 
were included in the Pearson correlation, a total only 219 data were available to analyze. TPO  
(r = .055, p = .285, two-tailed), T. gondii titers (r = .037, p = .477), BMI (r = .081, p = .117) and 
EBV IgG titers (r = -.078, p = .251) were not significantly correlated to POMS-D or other key 
variables. Due to the sample size and to avoid the risk of affecting statistical power, BMI and 
EBV antibody titers were not included in the final hypotheses analysis. 
           The final 380 women with the 17 data variables were entered in the Pearson correlation 
analysis. Table 6 provides correlations for all linear variables. The perceived stress scores (PSS) 
were highly positively correlated to POMS-D (r =.601, p =.000) and POMS-F (r =.43, p =.000) 
and negatively correlated to age (r =-.125, p =.015). POMS-D scores were positively correlated 
to POMS-F (r =.55, p =.000) and number of children (r =.173, p = .001), HSV-2 (r = .215, p 
=.000), and negatively correlated with HHV-6 (r = -.130, p = .011) and phenylalanine (r = -.152, 
p =.003) (Table 6).    
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Table 6 
Correlation of Key Variables in the Current Study (N=380) 
 
Variable POMS
-D 
POMS
-F 
PSS Age #childr HSV
-1 
HSV 
-2 
HHV 
-6 
CMV Neo Nitr TRP Kyn Kyn/ 
Trp 
Phe Tyr Phe/ 
Tyr 
POMS-D 1                 
POMS-F  .55ǂ 1                
PSS  .60ǂ  .43ǂ 1               
Age  .01  .01 -.13* 1              
#childr  .17ǂ  .05  .14ǂ  .25ǂ 1             
HSV-1  .03 -.16ǂ  .05  .01  .27ǂ 1            
HSV-2  .22ǂ  .04  .11*  .08  .18ǂ  .14ǂ 1           
HHV-6 -.13*  .02 -.11* -.01 -.20ǂ -.30ǂ -.15ǂ 1          
CMV   .03 -.06  .01  .03  .16ǂ  .23ǂ  .22ǂ -.09 1         
Neo  -.02  .09  .00  .06  .08  .01 -.06  .08  .13ǂ 1        
Nitr   .05  .01  .05  .02  .09  .04 -.02 -.09  .01 -.04 1       
TRP  -.07 -.04 -.07  .02 -.15ǂ -.15ǂ -.09  .16ǂ -.04  .06  .06 1      
KYN  -.00  .08  .03  .03 -.01 -.04 -.05  .13* -.03 -.36ǂ -.04  .38ǂ 1     
Kyn/Trp   .04  .08  .08 -.01  .10*  .07 -.01  .01 -.01  .33ǂ -.07 -.24ǂ  .77ǂ 1    
Phe  -.15ǂ -.03 -.13*  .05 -.09 -.14ǂ -.10*  .16ǂ -.07  .16ǂ  .15ǂ  .63ǂ  .23ǂ -.16ǂ 1   
Tyr  -.06 -.01 -.03  .03 -.07 -.08 -.06  .05  .04 -.07  .06  .54ǂ  .07 -.26ǂ  .70ǂ 1  
Phe/Tyr  -.02 -.06  .06  .12*  .01 -.08 -.05 -.12* -.11*  .17ǂ -.01  .01  .09   .09  .12*  .33* 1 
Note. POMS-D: Profile of Mood States-Depression, POMS-F: Profile of Mood States-Fatigue, PSS: perceived stress scale, #childr: Number of children,  
HSV-1: Herpes simplex virus type 1, HSV-2: Herpes simplex virus type 2, HHV-6: Human herpes virus-6, CMV: cytomegalovirus, Neo: Neopterin, Nitr: Nitrite, 
TRP: Tryptophan, KYN: Kynurenine, Kyn /Trp: Kynurenine/ Tryptophan, Phe: Phenylalanine, Tyr: Tyrosine, Phe /Tyr: Phenylalanine /Tyrosine 
 N=380, Listwise. *P < .05   ǂP < .01, two-tailed test.
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           The variables that were significantly related to POMS-depressive symptoms or POMS-
fatigue subscale scores were entered into multiple regression analysis to examine the 
relationships between stress, herpes viral titers, and depressive symptoms or fatigue symptoms. 
Depressive Symptoms and Biomarkers 
           Initial analyses of independent t-tests were conducted to assess two groups of women, 
POMS-D score > 20 and POMS-D score ≤ 20 (Table 7).  The PSS scores, biomarkers, herpes 
viral titers and biogenic amines levels were compared. The clinically depressed women (POMS-
D > 20) had a significantly higher PSS scores and HSV-2 titers than the women with POMS-D 
score ≤ 20. They also had a lower HHV-6 titers, tryptophan and phenylalanine levels than the 
women with POMS-D score ≤ 20. Additionally, clinically depressed women had higher nitrite,  
KYN /TRP ratios, HSV-1, CMV, EBV antibody titers and lower neopterin, kynurenine, tyrosine, 
and Phe /Tyr ratios but they none were statistically significant (p > .05). Among twenty-five 
clinically depressed (POMS-D > 20) women, ten were African American and seven were 
Hispanic.  
Data Analysis to Address the Hypothesis 
Hypothesis 1 
           There is a significant positive relationship between stress and depressive symptoms in 
pregnant women. 
           Log-10 transformed POMS-D score were used in the hypothesis analysis to correct 
skewness and better meet the assumption of the normality. The regression equation is given by:  
(Y’1) = a +b1 (x1). Y’1 (POMS-D) can be expressed in terms of a constant /intercept (a) and a 
slope (b1) times the (x1) variable. When the independent variable perceived stress (PSS) alone is 
entered into the regression analysis, the regression equation is given by:  
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(Y’1) = -.249 +.037 (PSS). The perceived stress (β = .575, p = .000,    = .331, adjusted    = 
.329) was a strong influence on the POMS-D scores (Figure 4).  
 
Table 7   
Summary T-Tests of Variables in Women with POMS-D Score > 20 and POMS-D Score ≤ 20 
Group 
            
Variable Score M SD t Mean 
Difference 
95% CI    
        
PSS Score POMS-D > 20  34.80   5.94 10.50**   13.66 11.10 to 16.22 .224 
                 ≤ 20  21.14   6.31     
HSV-1 POMS-D > 20   3.57   2.72   1.19    
                 ≤ 20   2.92   2.62     
HSV-2 POMS-D > 20   3.18   4.26   2.36*   2.04 .27 to 3.81 .015 
                 ≤ 20   1.14   2.31     
HHV-6 POMS-D > 20   7.62   4.07 -4.23**  -3.71 -5.50 to -1.92  .045 
                 ≤ 20 11.33   6.22     
CMV POMS-D > 20   2.70   2.61   -.09    
                 ≤ 20   2.75   2.53     
EBVǂ POMS-D > 20 21.06   9.69   -.96    
                 ≤ 20 23.39   8.69     
Nitrite POMS-D > 20 21.52 14.63    .89    
                 ≤ 20 18.96 13.80     
Neopterin POMS-D > 20   5.41   1.37 -1.05    
                 ≤ 20   5.85   2.11     
Tryptophan POMS-D >20 54.70 10.81 -2.69**  -8.11 -14.05 to -2.17 .018 
                 ≤ 20 62.81 14.82     
Kynurenine POMS-D > 20   1.82     .68   -.56    
                 ≤ 20   1.90     .75     
KYN /TRP POMS-D > 20 33.35 11.53  1.03    
                 ≤ 20 30.94 11.50     
Phenylalanine POMS-D > 20 42.93 13.51 -3.27*** -10.01 -16.06 to -4.01 .027 
                 ≤ 20 53.00 14.98     
Tyrosine POMS-D > 20 45.02 14.29   -.17    
                 ≤ 20 51.06 17.05     
Phe /Tyr POMS-D > 20     .98     .21 -1.18    
                 ≤ 20   1.09     .50     
        
Note. M: Mean, SD: Standard deviation, PSS: Perceived Stress Scale, POMS-D: Profile of Mood States-Depression, 
HSV-1: Herpes simplex virus type 1, HSV-2: Herpes simplex virus type 2, HHV-6: Human herpes virus-6, CMV: 
Cytomegalovirus, EBV: Epstein-Barr virus, KYN/TRP: Kynurenine /Tryptophan, Phe/Tyr: Phenylalanine /Tyrosine 
 df = 378, *P <.05, **P <.01, *** P < .001, two-tailed.  EBVǂ df =217. 
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Figure 4. Scatter plot of log-10 transformed Prenatal Profile of Mood States-Depression (POMS-
D) scores (Y-axis) and perceived stress scores (X-axis) in a linear regression relationship     
 
           Perceived stress and demographic variables. The perceived stress was negatively 
correlated to age (r = -.125, p = .015) (Table 6). The independent demographic variables (age, 
African American, number of children) and perceived stress were entered to assess interference 
with dependent variable depressive symptoms. To examine the possible suppression effect 
among demographic variables and perceived stress, they were entered separately in the 
regression model. R squared (  ), standardized regression weight, zero-order and the partial 
correlation coefficient sign and size were compared. The results showed that being African 
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American (AA), number of children and age had some degree of correlation. They also 
correlated with perceived stress. The age variable was a major suppressor; as it suppressed other 
independent variables. Therefore, the age was removed from regression analysis to reduce the 
potential suppression effect. The perceived stress was positively associated with number of 
children (β = .147, p = .006) and the African American race (β = .123, p = .022). 
           Depressive symptoms and perceived stress. Hierarchical multiple regression was used 
to assess the ability of prenatal perceived stress in predicting levels of depressive symptoms after 
controlling for race (African American) and number of children. Independent variables African 
American race and number of children were entered at Step 1, explaining 1.3 % of the variance 
in depressive symptoms. After entry of the perceived stress in Step 2 the total variance explained 
by the model as a whole was 33.1 %. The perceived stress explained the additional 31.8 % of the 
variance. Table 8 summarizes the multiple regressions analyses. The results suggest perceived 
stress (β = .577, p = .000) strongly predicted depressive symptoms. 
Table 8 
Relationship between Prenatal Depressive Symptoms and Perceived Stress (N=380) 
 
                       Step 1                   Step 2 
Variable   B  SE B    β        B   SE B      β    
 
Intercept .529 .032     -.250 .064   
AA .092 .057  .083   -.012 .048 -.011 
#Children .026 .021  .064    .001 .017  .002 
PSS       .037 .003  .577*** 
        
    = .013 
Adjusted    = .008 
     = .331 
Adjusted    = .326 
F(3, 376) = 62.054*** 
 
    
   F(2, 377) = 2.501    
        
    change = .318       
 F change (1, 376) = 178.800***     
Note. AA: African American, #Children: Number of children, PSS: Perceived Stress Scale 
  ***P<.001 
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           Summary of hypothesis 1. As expected, there was a significantly positive relationship 
between perceived stress and depressive symptoms in pregnant women. The key predictor, 
perceived stress, accounted for 31.8% of the variance in prenatal depression model. Women in 
the African American group showed higher stress scores. Also, the more children pregnant 
women had, the more stress they had. 
Hypothesis 2 
           There are significant positive relationships among herpes viral titers, stress and depressive 
symptoms in pregnant women.  
           During this exploratory analysis, independent sample t-tests, Pearson correlation and 
multiple regression analysis were used to understand each herpes viral seroprevalence status in 
association with prenatal perceived stress and depressive symptoms. 
           HSV-1 seropositive titers, perceived stress and depressive symptoms. Independent 
variables race (African American), number of children and perceived stress were entered at Step 
1 (   = .331, F (3, 376) = 62.054, p = .000). After entry of the HSV-1 seropositive titers in Step 
2, (   = .332, F (4, 375) = 46.495, p = .000),   change = .000, F change (1, 375) = .209,  
p = .648), the HSV-1 seropositive titers ((β = .020, p = .648) were not significantly associated 
with depressive symptoms. However, perceived stress (β = .577, p = .000) remained significantly 
associated with depressive symptoms.  
           Separate multiple regression analysis was used to explore relationship between perceived 
stress and HSV-1 seropositive titers. The dependent variable HSV-1 seropositive titers and 
independent variables PSS, race (American African), number of children were entered in the 
regression analysis (   = .074, F (3, 376) = 9.954, p = .000), the relationship between  
HSV-1 seropositive titers and PSS (β = -.011, p = .823) were not significant. 
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           HSV-2 seropositive titers, perceived stress and depressive symptoms.  From 
independent sample t-test analysis, the women with HSV-2 titers ≥ 1 (seropositive) had a 
significantly higher POMS-D score than the women with HSV-2 titers < 1 (seronegative) (Figure 
5 & Table 9). From Pearson correlation analysis, HSV-2 titers were correlated with POMS-D 
score (r = .215, p = .000, two-tailed), respectively (Table 6). 
 
 
 
 
 
 
 
 
                   *P < .05 
Figure 5. Significantly higher Profile of Mood States - Depression (POMS-D) scores in women 
with herpes simplex virus type 2 (HSV-2) seropositive titers 
 
Table 9 
Difference Scores in Women with Herpes Viral Titers above and below Threshold   
              
Variables Viral 
Serology 
M SD t Mean 
Difference 
95% CI    
POMS-Depression HSV-2 ≥ 1 8.12 11.63  2.29*  3.08 .41 to 5.75 .014 
 HSV-2 < 1 5.04 7.29     
        
Perceived stress 
scale (PSS) 
HHV-6 ≥6 21.63 7.11 -2.02* -1.74 -.3.42 to -.049 .011 
 HHV-6 <6 23.37 7.09     
        
POMS-Fatigue CMV ≥ 1 7.32 5.21 -3.15**  -1.74  -2.83 to-.66 .015 
 CMV < 1 9.06 5.47     
Note. HSV-2: Herpes simplex virus type 2, HHV-6: Human herpes virus-6, CMV: Cytomegalovirus, POMS: Profile 
of Mood States, df = 378, *P <.05, ** P <.01, *** P <.001, two-tailed.      
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          The dependent variable log -10 transformed POMS-D scores and independent variable 
HSV-2 seropositive titers (HSV-2≥ 1) only were entered into regression analysis (N=380). The 
results showed that HSV-2 seropositive titers (β = .102, p = .046),    =.010, F (1, 378) = 3.995,  
p = .046) significantly predicted depressive symptoms. HSV-2 seropositive titers remained 
significant to predict depressive symptoms (β = .085, p = .050),    =.338, F (3, 376) = 63.979,  
p = .000) after independent variables race (African American) and PSS were added. 
           Hierarchical multiple regression was used to understand the relationship between HSV-2 
seropositive titers and depressive symptoms. The full sample included independent variables race 
(African American), number of children and perceived stress which were entered at Step 1, 
explaining 33.1 % of the variance in depressive symptoms (   =.331, F (3, 376) = 62.054,  
p = .000). After entry of the HSV-2 seropositive titers at Step 2 total variances explained by the 
model as a whole was 33.8 % (   = .338, F (4, 375) = 47.868, p = .000). The HSV-2 seropositive 
titers (β = .086, p = .050) were significantly related to depressive symptoms (   change= .007,  
F change (1, 375) = 3.882, p = .050) (Table 10). 
Table 10 
Predictors of Prenatal Depressive Symptoms (N=380) 
 
                       Step 1                   Step 2 
Variable   B  SE B    β          B   SE B      β     
 
Intercept -.250 .064     -.264 .064   
AA -.012 .048 -.011   -.034 .049 -.031 
#children  .001 .017  .002   -.003 .017 -.007 
PSS  .037 .003  .577***    .038 .003  .578*** 
HSV-2 ≥1         .096 .049  .086* 
    = .331 
Adjusted    = .326 
     = .338 
Adjusted    = .331 
F(4, 375) = 47.868*** 
 
    
   F(3, 376) =62.054***    
 F change (1, 375) = 3.882*     
Note. AA: African American, #children: Number of children, PSS: Perceived Stress Scale,  
HSV-2: Herpes simplex virus type-2, *P <.05, ***P <.001 
50 
 
           To explore relationship between perceived stress and HSV-2 seropositive titers in full 
sample (N = 380), the dependent variable HSV-2 seropositive titers and independent PSS, race 
(African American) and number of children were entered (  = .074, F (3, 376) = 10.280,  
p = .000), the relationship between HSV-2 seropositive titers and PSS (β = -.015, p = .768) were 
not significant. 
           Women with higher HSV-2 seropositive titers had more depressive symptoms. Table 11 
provides Pearson correlation analysis of key variables in women with HSV-2 seropositive titers 
(N=83). The HSV-2 seropositive titers were entered as a continuous variable in a separate 
regression analysis to examine whether women with higher HSV-2 seropositive titers had more 
depressive symptoms. The results revealed that HSV-2 seropositive titers (β = .227, p = .039), 
  = .051, F (1, 81) = 4.392, p = .039) strongly predicted depressive symptoms.  
           The hierarchical multiple regression was used and independent variables race (African 
American), number of children and HSV-2 seropositive titers were entered one at a time. The 
size and sign of the independent variables zero-order and partial order were examined to identify 
potential suppression effects. The number of children variable was a negative suppressor. The 
number of children has positive correlation with other independent and dependent variables, 
however when entered into multiple regression analysis, the number of children had a negative  
β weight. HSV-2 seropositive titers (β = .249, p = .028) were significantly correlated with 
depressive symptoms after controlling for race (African American) and number of children 
(Figure 6 & Table 12). 
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Table 11 
Correlation of key Variables in Women with HSV-2 Seropositive Titers (N=83) 
 
Variable POMS
-D 
PSS Age #childr HSV
-1 
HSV 
-2 
HHV 
-6 
CMV Neo Nitr TRP Kyn Kyn/ 
Trp 
Phe Tyr Phe/ 
Tyr 
POMS-D 1                
PSS   .70ǂ 1               
Age  -.05 -.20 1              
#childr   .09  .15   .15 1             
HSV-1   .09  .12  -.06  .31ǂ 1            
HSV-2   .23*  .24*   .01  .15 .28ǂ 1           
HHV-6 - .05 -.09  -.07 -.16 -.32ǂ -.24* 1          
CMV   .06  .08   .11  .10  .09  .28* -.17 1         
Neo  -.02 -.07   .04 -.06 -.03  .09  .05  .21 1        
Nitr   .01 -.06   .19  .06  .00 -.13  .23*  .10 -.05 1       
TRP  -.14 -.04  -.00 -.17 -.32ǂ -.09  .15  .15  .07 -.12 1      
KYN  -.04  .09  -.17 -.15 -.19 -.13  .08  .11  .21 -.08  .43ǂ 1     
Kyn/Trp   .14  .14  -.25* -.02  .05 -.04 -.00  .00  .20 -.06 -.13  .81ǂ 1    
Phe  -.28* -.26*   .05  -.13 -.37ǂ -.13  .29ǂ -.04  .12  .02  .67ǂ  .25* -.13 1   
Tyr  -.23* -.18   .03 -.15 -.31ǂ -.13  .04  .11  .05 -.15  .74ǂ  .23* -.20  .73ǂ 1  
Phe/Tyr  -.12  -.13   .12*  .01 -.12  .02  .37ǂ -.17  .12  .26*  -.05  .02  .09  .41* -.30ǂ 1 
Note. POMS-D: Profile of Mood States-Depression, PSS: perceived stress scale, #childr: Number of children, HSV-1: Herpes simplex virus type 1,  
HSV-2: Herpes simplex virus type 2, HHV-6: Human herpes virus-6, CMV: cytomegalovirus, Neo: Neopterin, Nitr: Nitrite, TRP: Tryptophan,  
KYN: Kynurenine, Kyn/Trp: Kynurenine/ Tryptophan, Phe: Phenylalanine, Tyr: Tyrosine, Phe/Tyr: Phenylalanine /Tyrosine 
 N=83, Listwise. *P < .05   ǂP < .01, two-tailed test. 
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Table 12 
Predictors of Prenatal Depressive Symptoms in HSV-2 Seropositive  
Women (N=83) 
 
Variable    B SE B   β 
 Intercept  .528 .116  
 AA  .034 .122  .032 
 # Children -.078 .042 -.211 
 HSV-2≥1 Titers  .042 .019  .249* 
    
      = .092      
 Adjusted    = .057           
   F (3, 79) = 2.662*  
Note. AA: African American, #children: Number of children,  
PSS: Perceived Stress Scale, HSV-2: Herpes simplex virus type-2, *P <.05 
 
 
Figure 6. Scatter plot of herpes simplex virus type 2 titers (HSV-2) (X-axis) and log-10 
transformed Profile of Mood States- Depression scores (POMS-D) (Y-axis) in seropositive 
women 
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           Women with higher perceived stress also had higher HSV-2 seropositive titers. 
Relationships between perceived stress and herpes seropositive titers were examined in this 
separate analysis. The dependent variable HSV-2 seropositive titers (N = 83) and independent 
variable PSS were entered in the regression model to explore whether the women with higher 
perceived stress had higher HSV-2 seropositive titers. The perceived stress (β = .235, p = .032) 
was significantly positively associated to HSV-2 seropositive titers (  = .055, adjusted 
   = .044, F (1, 81) = 4.756, p = .032). The higher perceived stress the pregnant women had, the 
higher HSV-2 titers they had (Figure 7). 
Figure 7. Scatter plot of herpes simplex virus type 2 (HSV-2) titers (Y-axis) and Perceived Stress 
Scale scores (X-axis) in seropositive women                            
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           The herpes viral titer (HSV-2) was a mediator between perceived stress and depressive 
symptoms. The mediation analysis of three regression equations provided evidence that the 
herpes viral titer (HSV-2) was a mediator, partially mediating the effect of perceived stress on 
depressive symptoms. Based on the results of hypothesis 1 and hypothesis 2, these regression 
equations can be summarized as follow: (1) perceived stress strongly predicted depressive 
symptoms (β = .577, p = .000) (Figure 4 & Table 8), (2) the higher perceived stress significantly 
predicted higher HSV-2 seropositive titers (β = .235, p = .032) (Figure 7), (3) the perceived 
stress (β = .578, p = .000) and HSV-2 seropositive titers (β = .086, p = .05) significantly 
predicted depressive symptoms (Table 10). 
           Regression analysis showed that both perceived stress and HSV-2 seropositive titers 
strongly predicted depressive symptoms (Table 10). This indicated that there were multiple 
mediating factors in this model. The severity of depressive symptoms increases as the level of 
stress increases, and this positive relationship was partially mediated by herpes viral titers in 
pregnant women; herpes viral titer (HSV-2) was the mediator /intervening variable.  
           Characteristics of women with HSV-2 seropositive titers.  Among the HSV-2 seropositive 
women (N = 83), the age ranged from 19-45 years old. African American (43.3 %) women had higher 
seroprevalence for the HSV-2 infection. Ten out of eighty-three HSV-2 seropositive women had a 
POMS-D score over 20 and were referred to their healthcare providers. Among HSV-2 seropositive 
women, 77.1 % also had the CMV infection, 71.1 % had the HHV-6 infection, 67.5 % had the HSV-1 
infection and 67.5 % had EBV infection (Table 13). 
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Table 13 
Demographic Characteristics and Herpes Viral Titers in Women with HSV-2  
Seropositivity (N=83) 
 
Variable 
 
            
 
 N           %              
HSV-2 Titer 
   
  M                SD 
POMS-D Score 
    
  M               SD 
Race       
  Caucasian 19 22.9 3.65 2.78   4.89   5.58 
  African America 36 43.4 6.09 3.37 10.19 15.20 
  Hispanic 22 26.5 5.66 2.42   8.50   9.54 
  Asian   2   2.4 4.64 0.78   5.00   4.24 
  Native America   1   1.2 3.14 -   0.00   0.00 
  Other   3   3.6 2.06 1.00   5.67   5.51 
     POMS-D>20, n=10 
Herpes Viral Seroprevalence     
  HSV-1 56   67.5     
  HHV-6 59   71.7     
  CMV 64   77.1     
  EBV 56   67.5     
       
Note. M: Mean, SD: Standard Deviation, POMSD: Profile of Mood States-Depression,  
HSV-1: Herpes simplex virus type 1, HSV-2: Herpes simplex virus type 2,  
HHV-6: Human herpes virus-6, CMV: Cytomegalovirus, EBV: Epstein-Barr virus 
 
           HHV-6 seropositive titers, perceived stress and depressive symptoms.  From 
independent sample t-tests analysis, the women with HHV-6 titers ≥ 6 (seropositive) women had 
a significantly lower PSS score than the women with HHV-6 titers < 6 (seronegative) (Table 9). 
From Pearson correlation analysis, the HHV-6 seropositive titers were negatively correlated with 
POMS-D score (r = -.130, p = .011) (Table 6).  
           When HHV-6 seropositive titers were entered in the regression analysis (   =.332, 
adjusted    = .325, F (4, 375) = 46.530, p = .000,   change = .001, F change (1, 375) = .304,  
p = .582), the HHV-6 seropositive titers (β = -.024, p = .582) were not associated with depressive 
symptoms. When dependent variable HHV-6 seropositive titers and independent variables PSS, 
race (African American) and number of children were entered in regression model (  =.033,  
F (3, 376) = 4.336, p = .005), the relationship between HHV-6 seropositive titers and PSS  
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(β = -.097, p = .063) was not significant. 
           CMV seropositive titers, perceived stress and depressive symptoms. From t-test 
analysis, there was no difference between POMS-D and PSS mean score in women with the 
CMV infection. When CMV seropositive titers were entered in the regression analysis (   = 
.333, adjusted    = .326, F (4, 375) = 46.751, p = .000,   change = .002, F change (1, 375) = 
.895, p = .343), the CMV seropositive titers (β = .042, p = .345) were not associated with 
depressive symptoms.  
           When dependent variable CMV seropositive titers and independent variables PSS, race 
(African American) and number of children were entered in regression model (   = .088,  
F (3, 376) = 12.070, p = .000), the relationship between CMV seropositive titers and PSS  
(β = -.062, p = .220) was not significant. 
           CMV seropositive titers, perceived stress and fatigue symptoms.  From the 
independent t-test results the women with CMV seroprevalence titers had a significant different 
POMS-Fatigue score (Table 9).  
           Perceived stress and fatigue symptoms. The perceived stress score was highly correlated 
with fatigue symptoms (POMS-F) (r = .426, p = .000) (Table 6). POMS-F score ranged from 0 to 
25, mean score was 8.04. To explore the relationship between perceived stress and fatigue 
symptoms, supplementary hierarchical multiple regression was used in full sample (N = 380). 
Independent variables race (African American), and numbers of children were entered at Step 1, 
explaining 1.7 % of the variance in fatigue symptoms. After entry of the perceived stress in Step 
2 the total variance explained by the model as a whole was 21.8% (   = .218, adjusted 
    = .212, F (3, 376) = 34.998, p = .000,   change = .201, F change (1, 375) = 96.713,  
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p = .000). The perceived stress explained the additional 20.1 % of the variance. The results 
suggest perceived stress (β = .459, p = .000) strongly predicts fatigue symptoms (Table 14). 
 
Table 14 
Relationship between Prenatal Perceived Stress and Fatigue Symptoms (N=380) 
 
                       Step 1                   Step 2 
Variable   B  SE B    β            B   SE B      β    
 
        
Intercept  8.098 .365       .909 .802   
AA -1.579 .662  -.124**  -2.530 .599 -.199*** 
#Children    .339 .244    .072     .109 .219   .023 
PSS        .346 .035   .459*** 
        
    = .017 
Adjusted    = .012 
     = .218 
Adjusted    = .212 
F(3, 376) = 34.998*** 
 
    
   F(2, 377) = 3.302*    
        
    change = .201     
 F change (1, 376) = 96.713***     
      
Note. AA: African American, #Children: Number of children, PSS: Perceived Stress Scale 
 *P <.05, **P < .01, ***P <.001 
 
           Perceived stress, depressive symptoms and fatigue symptoms. From Pearson correlation 
analysis, the depressive symptoms were highly correlated with fatigue symptoms (r = .546,  
p = .000). Hierarchical multiple regression was used to assess the ability of the prenatal 
perceived stress in predicting levels of fatigue symptoms after controlling for depressive 
symptoms, race (African American) and number of children. Independent variables race (African 
American), number of children, and depressive symptoms were entered at Step 1, explaining total 
of 33 % of the variance in fatigue symptoms. After entry of the perceived stress at Step 2 the 
total variance explained by the model as a whole was 35.5 %. The results suggest perceived 
stress (β = .198, p = .000) strongly predicts fatigue symptoms (Table 15). 
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Table 15 
Predictors of Prenatal Fatigue Symptoms (N=380) 
 
                       Step 1                   Step 2 
Variable   B  SE B    β        B   SE B      β    
 
        
Intercept  4.641 .401     2.221   .744   
AA -2.177 .549 -.171***  -2.470   .545 -.194*** 
#Children    .170 .202  .036     .104   .199  .022 
POMS-D  6.529 .493  .563***   5.247   .588  .452*** 
PSS        .149   .039  .198*** 
        
    = .330 
Adjusted    = .324 
     = .355 
Adjusted    = .348 
F(4, 375) = 51.625*** 
 
    
   F(3, 376) =61.671***    
        
 F change (1, 375) = 14.729***     
      
Note. AA: African American, #children: Number of children,  
POMS-D: Profile of Mood States-Depression, PSS: Perceived Stress Scale  
*P <.05, **P < .01, ***P <.001 
 
 
           CMV seropositive titers and fatigue symptoms. The CMV seropositive titers (N = 222) 
were entered as a continuous variable in a separate regression analysis to examine whether 
women with higher CMV seropositive titers had more fatigue symptoms. The results revealed 
that CMV seropositive titers (β = .142, p = .009) significantly positively predicted fatigue 
symptoms after controlling for  race (African American), number of children, perceived stress 
and depressive symptoms (   = .374, adjusted    = .360, F (5, 216) = 25.834, p = .000, F 
change (1, 216) = 6.963, p = .009) (Figure 8 & Table 16).  
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Figure 8. Scatter plot of women with Cytomegalovirus titers (CMV) (X-axis) and Profile of 
Mood States-Fatigue scores (POMS-F) (Y-axis) in seropositive women 
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Table 16 
Predictors of Prenatal Fatigue Symptoms in CMV Seropositive Women (N= 222) 
 
                       Step 1                   Step 2 
Variable   B  SE B    β           B   SE B      β    
 
        
Intercept  1.753 .962       .104 1.136   
AA -1.800 .633 -.162**  -1.796   .625 -.162** 
#Children    .203 .241  .047     .182   .238  .042 
PSS    .117 .051  .157*     .118   .050  .158* 
POMS-D  5.678 .747  .497***   5.646   .737  .494*** 
CMV ≥1        .372   .141  .142** 
        
    = .354 
Adjusted    = .342 
     = .374 
Adjusted    = .360 
F(5, 216) = 25.834*** 
 
    
   F(4, 217) =29.734***    
        
 F change (1, 216) = 6.963**     
      
 
Note. AA: African American, #children: Number of children, POMS-D: Profile of Mood States-
Depression, PSS: Perceived Stress Scale, CMV: Cytomegalovirus  
*P <.05, **P < .01, ***P <.001 
 
          Characteristics of women with CMV seropositive titers.  Among the CMV seropositive women 
(N = 222), the age ranged from 17-45 years old. African American (32.3 %), Caucasian (32.3 %) and 
Hispanic (26.9 %) women had seroprevalence for the CMV infection. The CMV titers were not 
statistically different between races (F (5, 216) = .759, p = .580) or POMS-F scores from analysis of 
variance (ANOVA).The CMV seropositive women had significantly different POMS-D scores (F (5, 
216) = 2.540, p = .029). Among the CMV seropositive women, 66.4 % also had the HSV-1 infection, 
64.6 % had the EBV infection, 43.9 % had the HHV-6 infection and 28.7 % had the HSV-2 infection 
(Table 17). 
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Table 17 
ANOVA of Sample Demographic Characteristics and Herpes Viral Titers in Women with CMV 
Seropositivity (N = 222) 
 
Variable 
 
            
 
 N         %              
  CMV Titer 
   
M             SD 
POMS-F Score 
    
  M           SD 
POMS-D Score 
 
 M            SD 
         
Race         
  Caucasian 71 32.0 4.24 2.08 7.65 4.75 3.13   5.21 
  African America 72 32.4 4.47 1.93 6.93 5.49 7.92 11.52 
  Hispanic 60 27.0 4.63 1.88 7.40 5.48 6.17   7.10 
  Asian   8   3.6 5.50 1.89 8.13 5.38 6.38   8.40 
  Native America   1   0.5 3.79 - 0.00 1.00 0.00   0.00 
  Other 10   4.5 4.20 2.49 7.40 4.99 7.00   5.98 
         
   F (5, 216) = .759 F (5,216) = .568 F (5,216) = 2.540* 
       POMS-D>20,n=10 
Herpes Viral Seroprevalence       
 HSV-1 148   66.4       
 HSV-2   64   28.7       
 HHV-6 161   43.9       
 EBV 143   64.6       
         
Note. M: Mean, SD: Standard Deviation, POMS-F: Profile of Mood States-Fatigue, POMS-D: 
Profile of Mood States-Depression, HSV-1: Herpes simplex virus type 1, HSV-2: Herpes 
simplex virus type 2, HHV-6: Human herpes virus-6, CMV: Cytomegalovirus,  
EBV: Epstein-Barr virus, *P <.05 
  
           Summary of hypothesis 2. Independent t-tests, Pearson correlation and regression 
analyses were performed on the separate herpes viral titers to explore the relationships among 
infection status, prenatal perceived stress, and depressive symptoms. Mediation analysis revealed 
that the herpes viral (HSV-2) seropositive titer was a mediator, partially mediating the effect of 
perceived stress on depressive symptoms. The HSV-2 seropositive titers were significantly 
positively associated with perceived stress and depressive symptoms in pregnant women; the 
women with higher perceived stress had higher HSV-2 seropositive titers and the women with 
higher HSV-2 seropositive titers had more depressive symptoms. African American women 
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(43.3 %) had higher depressive symptoms (POMS-D) scores and higher seroprevalence for the 
HSV-2 infection. Also, the women with CMV seropositive titers showed a positive association 
with prenatal fatigue symptoms after controlling for race (African American), number of 
children, perceived stress and depressive symptoms. However, the associations of perceived 
stress or depressive symptoms with HSV-1, HHV-6 and CMV seropositive titers were not 
statistically significant. 
Hypothesis 3 
           Kynurenine /tryptophan ratios, phenylalanine /tyrosine ratios, and neopterin levels are 
positively related to herpes viral titers in depressed pregnant women.   
           In this exploratory analysis, independent sample t-tests, Pearson correlation and multiple 
regressions were conducted to understand each herpes viral seroprevalence status in association 
with different biogenic amines and depressive symptoms.  
           The POMS-D (r = -.152, p = .003, two-tailed) and PSS scores (r = -.130, p = .011) were 
negatively correlated with phenylalanine. The following immune markers and amino acid levels 
were positively correlated: (1) nitrite with phenylalanine (r = .147, p = .004), (2) neopterin with 
phenylalanine (r = .159, p = .002), kynurenine (r = .355, p = .000), Phe /Tyr (r = .168,  
p = .001) and KYN /TRP ratios (r = .326, p = .000), (3) tryptophan with kynurenine (r = .384,  
p = .000), phenylalanine (r = .632, p = .000) and tyrosine (r = .543, p = .000), (4) phenylalanine 
with tyrosine (r = .692, p = .000).  
           Negative correlation between biogenic amines as follow: (1) tryptophan with KYN/TRP 
ratios (r = -.237, p = .000), (2) KYN /TRP ratios with phenylalanine (r = -.163, p = .001) and 
tyrosine (r = -.263, p = .000) (Table 6).  
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           POMS-D score > 20 group and biogenic amines. From t-test analysis, the women with 
POMS-D score > 20 group had significantly lower tryptophan and phenylalanine levels than the 
women with POMS-D score  ≤ 20 group (Figure 9, 10 & Table 7). 
 
 
 
 
 
 
 
 
                        **P <.01 
 Figure 9. Significantly lower tryptophan level in women Profile of Mood States- Depression 
(POMS-D) >20 group 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      ***P <.001 
Figure 10. Significantly lower phenylalanine level in women Profile of Mood States- Depression 
(POMS-D) >20 group 
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           HSV-1 seroprevalence and biogenic amines. From t-test analysis, the women with 
HSV-1 seropositive titers had significantly lower tryptophan and phenylalanine levels than the 
women with HSV-1 seronegative titers (Figure 11, 12 & Table 18). From Pearson correlation 
analysis, HSV-1 titers were negatively correlated with tryptophan (r = -.152, p = .003) and 
phenylalanine (r = -.141, p = .006) (Table 6). 
           Multiple regression analyses were used to assess relationships between depressive 
symptoms and independent variables HSV-1 seropositive titers, and biogenic amines. When race 
(African American), number of children, HSV-1seropositive titers, and perceived stress were 
entered at Step 1, 33.2 % of variability in depressive symptoms was explained (F (4, 375) = 
46.495, p = .000). Each biogenic amine was entered separately in Step 2. None of biogenic 
amines significantly influenced depression: for neopterin (β = .029, p = .508); for Phe /Tyr ratios  
(β = -.029, p = .662); for KYN /TRP ratios (β = -.033, p = .440). 
 
 
 
 
 
 
 
 
      
 
                  **P <.01 
   Figure 11. Significantly lower tryptophan level in women with herpes simplex virus  
  (HSV-1) seropositive titers 
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                            *P <.05 
  Figure 12. Significantly lower phenylalanine level in women with herpes simplex virus  
  (HSV-1) seropositive titers 
 
Table 18 
Summary Independent T-Test Biogenic Amines in HSV-1 Titers above and below Threshold  
(N = 380) 
                
Variable Viral 
Serology 
M SD t Mean 
difference 
95% CI    
 
Tryptophan 
 
HSV-1 ≥ 1 
 
60.51 
 
13.29 
 
-2.73** 
 
-4.13 
 
  -7.10 
 
.019 
             < 1 64.63 16.17   to -1.07  
kynurenine HSV-1 ≥ 1   1.88     .69  -.53    
             < 1   1.92     .81     
KYN / TRP HSV-1 ≥ 1 31.89 11.60  1.53    
             < 1 30.06 11.31     
Neopterin HSV-1 ≥ 1           5.78   1.95  -.50    
             < 1   5.87   2.21     
Nitrite HSV-1 ≥ 1 19.79 14.34 1.07    
             < 1 18.26 13.17        
Tyrosine HSV-1 ≥ 1 49.89 16.25    .47    
             < 1 51.71 17.90     
Phenylalanine HSV-1 ≥ 1 50.57 14.00 -2.65** -4.11   -7.16 .018 
             < 1 54.18 16.15   to -1.06  
Phe /Tyr HSV-1 ≥ 1   1.05     .23 -1.81    
             < 1   1.14     .70     
      KYN/TRP: Kynurenine/ Tryptophan, Phe/Tyr: Phenylalanine /Tyrosine, HSV-1: Herpes simplex 
virus type 1, df = 378, **P <.01, two-tailed.   
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           HSV-2 seroprevalence and biogenic amines. From t-test analysis, the women with 
HSV-2 seropositive titers had significant lower neopterin level than the women with HSV-2 
seronegative titers (Figure 13 & Table 19). 
           When race (African American), number of children, HSV-2 seropositive titers, and 
perceived stress were entered at Step 1, explaining 33.8 % of variability in depressive symptoms 
(F (4,375) = 46.868, p = .000). Each biogenic amine was entered separately in Step 2. None of 
biogenic amines significantly influenced depression: for neopterin (β = -.006, p = .885); for  
Phe /Tyr ratios (β = .030, p = .488); for KYN /TRP ratios (β = -.028, p = .506). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            *P<.05 
 
      Figure 13. Significantly lower neopterin level in women with herpes simplex virus type 2 
      (HSV-2) seropositive titers 
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Table 19  
Summary Independent T-Test Biogenic Amines in HSV-2 Titers above and below Threshold  
                
Variable Viral 
Serology 
M SD t Mean 
difference 
95% CI    
 
Tryptophan 
 
HSV-2 ≥ 1 
 
60.83 
 
15.19 
 
-1.01 
   
             < 1 62.68 14.59     
kynurenine HSV-2 ≥ 1   1.83     .81   -.94    
             < 1   1.92     .72     
KYN /TRP HSV-2 ≥ 1 30.47 11.79   -.62    
             < 1 31.28 11.43     
Neopterin HSV-2 ≥ 1           5.48   1.41 -2.25* -.45 -.85 to-.06 .015 
             < 1   5.92   2.21     
Nitrite HSV-2 ≥ 1 19.56 14.87    .32    
             < 1 19.01 13.58        
Tyrosine HSV-2 ≥ 1 49.77 15.04  -.54    
             < 1 50.92 17.50     
Phenylalanine HSV-2 ≥ 1 50.18 15.63   -.15    
             < 1 52.94 14.89     
Phe /Tyr HSV-2 ≥ 1    1.03     .22 -1.27    
             < 1    1.10     .54     
        
       KYN /TRP: Kynurenine /Tryptophan, Phe /Tyr: Phenylalanine /Tyrosine,  
HSV-2: Herpes simplex virus type 2, df = 378   *P <.05, two-tailed.     
 
            HHV-6 seroprevalence and biogenic amines. From t-test analysis, the women with 
HHV-6 seropositive titers had significant higher tryptophan, kynurenine and phenylalanine 
levels than the women with HHV-6 seronegative titers (Figure 14, 15, 16 & Table 20). From 
Pearson correlation analysis, HHV-6 titers were positively correlated with tryptophan (r = .158,  
p = .002), kynurenine (r = .127, p = .013) and phenylalanine (r = .163, p = .001) (Table 6).  
           Race (African American), number of children, HHV-6 seropositive titers, and perceived 
stress entered in the multiple regression at Step 1, explained 33.2 % of variability in depressive 
symptoms (F (4, 375) = 46.530, p = .000). Each biogenic amine was entered separately in Step 2. 
None of biogenic amines significantly influenced depression: for neopterin (β = -.012, p = .785); 
for Phe /Tyr ratios (β = .028, p = .513); for KYN /TRP ratios (β = -.030, p = .479). 
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                                      *P <.05 
 
      Figure 14. Significantly higher tryptophan level in women with human herpes virus-6 
      (HHV-6) seropositive titers 
 
       
 
 
 
 
 
 
 
                            *P < .05 
 
            Figure 15. Significantly higher kynurenine level in women with human herpes virus-6 
           (HHV-6) seropositive titers 
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                           *P < .05 
 
     Figure 16. Significantly higher phenylalanine level in women with human herpes virus-6 
     (HHV-6) seropositive titers 
 
Table 20 
Summary Independent T-Test Biogenic Amines in HHV-6 Titers above and below Threshold  
                
Variable Viral 
Serology 
M SD t Mean 
difference 
95% CI    
 
Tryptophan 
 
HHV-6 ≥ 6 
 
63.19 
 
14.81 
 
2.19* 
 
3.89 
 
.41 to 7.36 
 
.013 
              < 6 59.31 14.04     
kynurenine HHV-6 ≥ 6   1.94     .76 2.12*   .19 .14 to .37 .013 
              < 6   1.75     .69     
KYN /TRP HHV-6 ≥ 6 31.38 11.55   .85    
              < 6 30.20 11.34     
Neopterin HHV-6 ≥ 6   5.88   2.14   .89    
              < 6   5.97   1.82     
Nitrite HHV-6 ≥ 6 18.91 14.27  -.56    
              < 6 19.84 12.43        
Tyrosine HHV-6 ≥ 6 50.99 17.14   .65    
              < 6 49.65 16.51     
Phenylalanine HHV-6 ≥ 6 53.30 15.46 2.24* 4.05 .50 to 7.61 .013 
              < 6 49.24 13.40     
Phe /Tyr HHV-6 ≥ 6   1.10     .54 1.27    
              < 6   1.03     .22     
        
      KYN /TRP: Kynurenine /Tryptophan, Phe /Tyr: Phenylalanine /Tyrosine,  
HHV-6: Human herpes virus-6, d f = 378    *P< .05, two-tailed. 
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           CMV seroprevalence and biogenic amines. From t-test analysis, the women with CMV 
seropositive titers had significant lower phenylalanine /tyrosine ratios than the women with 
CMV seronegative titers (Figure 17 & Table 21). From Pearson correlation analysis, CMV 
seropositive titers were negatively correlated with phenylalanine /tyrosine ratios (r = -.110,  
p = .032) and positively correlated with neopterin (r = .133, p = .009) (Table 6). 
           Multiple regression analyses were used with race (African American), number of children, 
CMV seropositive titers, and perceived stress entered at Step 1, explaining 33.3 % of variability 
in depressive symptoms (F (4, 375) = 46.751, p = .000). Each biogenic amine was entered 
separately in Step 2. None of biogenic amines significantly influenced depression: for neopterin 
(β = -.016, p = .704); for Phe /Tyr ratios (β = .033, p = .751); for KYN /TRP ratios (β = -.031,  
p = .472). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                       *P <.05 
Figure 17. Significantly lower phenylalanine /tyrosine (Phe /Tyr) ratios in women with 
cytomegalovirus (CMV) seropositive titers 
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Table 21  
Summary Independent T-Test Biogenic Amines in CMV Titers above and below Threshold  
                
Variable Viral 
Serology 
M SD t Mean 
difference 
95% CI    
 
Tryptophan 
 
CMV ≥ 1 
 
61.50 
 
14.66 
 
-1.22 
 
 
 
 
 
 
           < 1 63.37 14.79     
kynurenine CMV ≥ 1   1.87     .74 -1.01    
           < 1   1.94     .75     
KYN /TRP CMV ≥ 1 30.95 11.19   -.30    
           < 1 31.31 11.97     
Neopterin CMV ≥ 1   5.94   2.21  1.19    
           < 1   5.68   1.82     
Nitrite CMV ≥ 1 19.33 12.83    .33    
           < 1 18.85 15.21        
Tyrosine CMV ≥ 1 51.02 16.79    .48    
           < 1 50.17 17.29     
Phenylalanine CMV ≥ 1 51.22 14.79 -1.72    
           < 1 53.91 15.39     
Phe /Tyr CMV ≥ 1   1.04     .22 -2.42* -.12 -.22 to-.02 .015 
           < 1   1.16     .71     
        
      KYN /TRP: Kynurenine /Tryptophan, Phe /Tyr: Phenylalanine /Tyrosine,  
CMV: Cytomegalovirus, df = 378, *P < .05, two-tailed.         
 
           The separate hierarchical regression analysis was performed to assess the relationship 
between CMV seropositive titers (N = 222) and biogenic amine pathway. Independent variables 
neopterin, perceived stress, race (African American) and number of children were entered at Step 
1 explaining 30.4 % of variance in the depression model (   = .304, adjusted    = .288,  
F (5, 216) = 18.898, p = .000). After entry of the Phe /Tyr ratios at Step 2 the Phe /Tyr ratios 
explained an additional 1.8 % of the variance in depressive symptoms (   = .322, adjusted  
   = .303, F (6, 215) = 17.038, p = .000,   change = .018, F change (1, 215) = .5.687, p = .018). 
The Phe /Tyr ratios (β = -.144, p = .018) were negatively associated with depressive symptoms 
(Figure 18 & Table 22). The CMV seropositive titers were not significantly associated with 
tryptophan, kynurenine and KYN /TRP ratios in the depression model.   
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Table 22 
Predictors of Depressive Symptoms in CMV Seropositive Titers (N= 222) 
 
                   Step 1 
 
                       Step 2 
Variable   B  SE B    β        B   SE B      β    
 
        
Intercept -.170 .121      .125 .172   
AA -.027 .058 -.028   -.020 .057 -.020 
#Children -.021 .022 -.055   -.020 .022 -.052 
PSS  .037 .004  .564***    .035 .004  .539*** 
CMV≥1  .005 .013  .020    .002 .013  .007 
Neopterin -.008 .012 -.037    .002 .012  .011 
Phe /Tyr    
 
     -.298 .125 -.144* 
    = .304 
Adjusted    = .288 
     = .322 
Adjusted    = .303 
F(6, 215) = 17.038*** 
 
    
   F(5, 216) = 18.898***    
        
 F change (1, 215) = 5.687*     
 
Note. AA: African American, #Children: Number of children, PSS: Perceived Stress Scale  
KYN /TRP: Kynurenine / Tryptophan, Phe /Tyr: Phenylalanine /Tyrosine  
CMV: Cytomegalovirus  
*P <.05, ***P <.001   
 
           The associations of depressive symptoms or HSV-1, HSV-2, HHV-6 seropositive titers 
with biogenic amines were not statistically significant from the multiple regression analysis. 
Therefore, the path analysis initially planned in the dissertation proposal was excluded from the 
final hypothesis 3 analysis. 
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Figure 18. Scatter plot of Phenylalanine /Tyrosine (Phe /Tyr) ratios (X-axis) and log-10 
transformed POMS-Depression scores (Y-axis) in cytomegalovirus (CMV) seropositive women 
 
           Summary of hypothesis 3. From the t-test analyses, the POMS-D score > 20 and HSV-1 
seropositive group had significantly lower tryptophan and phenylalanine levels, the HSV-2 
seropositive group had lower neopterin level, the HHV-6 seropositive group had higher 
tryptophan, kynurenine and phenylalanine levels and the CMV seropositive group had lower  
Phe /Tyr ratios. 
           From the Pearson correlation analyses, POMS-D and perceived stress scores were 
negatively correlated with phenylalanine levels. The following immune markers and amino acids 
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levels were positively correlated: (1) nitrite with phenylalanine, (2) neopterin with 
phenylalanine, kynurenine, Phe /Tyr and KYN/TRP ratios, (3) tryptophan with kynurenine, 
phenylalanine and tyrosine, and (4) phenylalanine with tyrosine.  
           Tryptophan concentrations were negatively correlated with KYN/TRP ratios and  
KYN /TRP ratios were negatively correlated with phenylalanine and tyrosine. Negative 
correlation between seropositive herpes viral titers and biogenic amines were as follows: HSV-1 
with tryptophan and phenylalanine; CMV with Phe /Tyr ratios. Positive correlation between 
seropositive herpes viral titers and biogenic amines were as follows: HHV-6 with tryptophan, 
kynurenine and phenylalanine; CMV with neopterin. 
           The Phe /Tyr ratios were negatively correlated with depressive symptoms in women with 
CMV seropositive titers. However, there were no statistically significantly associations between 
the HSV-1, HSV-2, HHV-6 infection and the KYN /TRP or Phe /Tyr ratios from multiple 
regressions analysis.  
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CHAPTER FIVE 
 
DISCUSSION 
 
Hypothesis 1: Prenatal Stress and Depression     
           The national prevalence of depression in ages over 18 years is 16.6 % (Kessler et al., 
2005). The prevalence of depression for women is between 6 % and 17 % (Kessler, 2003; Pratt, 
Xu, McQuillan & Robitz, 2012). The incidence of prenatal depression increases to 20 % during 
pregnancy (Bonari et al., 2004). In the current prenatal study, the clinical depression (POMS-D 
 > 20) rate was 6.6 % compared to 12.7 % from Lancaster and colleagues review (2010).  
           The main finding from this study is that women with higher POMS-D scores had 
statistically significantly higher perceived stress; the perceived stress was a strong predictor of 
prenatal depressive symptoms. This relationship remained significant after controlling for race 
and number of children. This study sample (N = 380) provides robust evidence of the 
relationship between depression and perceived stress in pregnant women, comparable to 
Christian and colleagues (2009) who reported similar results with a small sample (N = 60).      
           In general, stress and depression scores are higher in low income and low education 
populations (Fagundes et al., 2012). In this study, women in the African American group had 
higher perceived stress and depression scores. Also, the more children pregnant women already 
had prior to being admitted to the study the more stress they had. These results reflect that 
pregnant women may lack social support or coping skills during stressful events. Similarly, 
Cassidy-Bushrow and colleagues (2012) reported that African American women have more 
depressive symptoms than non- African American in both non-pregnant and pregnant women. 
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           Stress in early pregnancy has an extremely negative influence on psychological and 
physiological responses which may include depression, premature birth or pregnancy failure 
(Parker & Douglas, 2010; Coussons-Read, Okun & Nettles, 2007). Psychosocial stressors during 
pregnancy include daily hassles, job status, low income, low education, life experience, domestic 
violence and lack of social support (Lancaster et al., 2010). Wood and colleagues (2010) 
suggested that increased stress showed association with prenatal depressive symptoms.  
Escriba-Aguir and colleagues (2012) reported that poor social support or depression was a strong 
predictor of postpartum depression.  
Hypothesis 2: Prenatal Perceived Stress, Herpes Viral Titers and Depression 
           Stress has been associated with a diminished T-cells response, such as reduction of 
cytokine production, memory T-cells and cytotoxic T-cells, which mediate killing herpes viral 
infection cells. Herpes viral IgG titers, a measure of latent herpes viral reactivation, are usually 
used in psychoneuroimmunology research. Elevated herpes viral IgG antibody titers reflect 
ineffective cellular immunity control over herpes viral reactivation (Glaser & Kiecolt-Glaser, 
1994; Fagundes et al., 2012). T-cells respond to herpes viral reactivation, resulting in production 
of IFN-γ which mediates tryptophan depletion and causes depressive symptoms.  
           The important finding from this hypothesis testing was that the HSV-2 seropositive titers 
were associated with perceived stress and depressive symptoms in pregnant women; CMV 
seropositive titers were related to perceived stress and fatigue symptoms.  
           Herpes simplex virus (HSV). The HSV-1 seropositive rate was 57.8 % and the HSV-2 
rate was 22 % in the current study. This result was similar to reports from prior studies: Straface 
and colleagues (2012) reported that pregnant women’s HSV-2 infection rate was 22 % and 
Carter (2013) reported HSV-1 seroprevalence of 68 % of individuals aged over 12 in the United 
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States. The rate of co-infection with HSV-1 and HSV-2 in individuals aged over 12 was 16.6 % 
in the U.S. (Avgil & Ornoy, 2006). 
           The significant finding from the current study was that results were consistent when either 
using the full sample or the HSV-2 seropositive sample only, showing that HSV-2 seropositive 
titers were strongly associated with depressive symptoms. This relationship remained significant 
after controlling for race and number of children. Among only those with HSV-2 seropositive 
titers were entered in the multiple regression analysis, the women with higher perceived stress 
had higher HSV-2 seropositive titers which were strongly associated with depressive symptoms. 
The study findings were similar to Pratt and colleagues (2012), who reported that 19 % of people 
are HSV-2 seropositive and the depression rates in HSV-2 seropositive individuals was 7 % in 
general population of ages 20-59. People with HSV-2 infection were more likely to have 
depression.  
           Furthermore, this study found that African American women had higher HSV-2 
seropositive rates and greater depressive symptoms than non-African American women.  This 
result was similar to Gottlieb and colleagues (2002), who reported that black women had the 
highest overall HSV-2 seroprevalence in a study of five sexually transmitted-disease clinics. 
Also, this finding was similar to Borders and colleagues (2010) and Christian and colleagues 
(2012) who reported that African American women had higher perceived stress levels and herpes 
viral (EBV) titers in their studies. Races, culture, psychosocial status, biological factors (e.g. 
depression gene or epigenetic factors) or pathogenicity in different types of herpes virus may 
influence gene-gene or gene-environmental interaction and result in development of depressive 
symptoms. 
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           Approximately 2-3 % of women had the primary HSV-2 genital herpes during pregnancy 
(Straface et al., 2012; Avgil & Ornoy, 2006). Two thirds of these pregnant women were 
asymptomatic (Avgil & Ornoy, 2006). Up to 90 % of HSV infection is undiagnosed and 
untreated (Perozzi et al., 2007; Pereira et al., 2003). Women usually feel psychological distress 
such as anger, denial, guilt, low self-esteem or depression after diagnosis with genital herpes.  
           Complications of HSV infection during pregnancy not only affect maternal health but also 
fetal and neonatal health. Nearly 85 % of HSV-2 transmission from mother to fetus occurs 
during delivery, while 5 % is caused by intrauterine infection. HSV-2 infection can cause 
miscarriage, stillbirth, congenital herpes and neonatal herpes infections for pregnant women with 
primary or recurrent HSV-2 infection (Straface et al., 2012; Corey & Wald, 2009; Perozzi et al., 
2007; Avgil & Ornoy, 2006; Pereira et al., 2003). 
           Prenatal related depression is stated to be the leading cause of death during pregnancy. 
This study contributes to the limited literature on relationships between perceived stress, HSV-2 
and depression among pregnant women. Mediation analysis revealed that HSV-2 was a mediator, 
partially mediating the effect of perceived stress on depressive symptoms. Prenatal perceived 
stress promoted HSV-2 reactivation and higher HSV-2 seropositive titers predicted prenatal 
depressive symptoms.  
           This study did not find a significant association between depressive symptoms and the 
prevalence of antibodies to other neurotropic herpes viruses, including HSV-1, HHV-6, CMV 
and EBV. This finding is consistent with findings of other studies (Christian et al., 2012; 
Amsterdam & Hernz, 1993). 
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           Cytomegalovirus (CMV).  Pregnant women infected with CMV can vertically transmit 
virus to fetus and cause the congenital CMV infection, hearing deficit, visual impairment or 
mental retardation (Walker, Palma-Dias, Wood, Shekleton & Giles, 2013). Women with a CMV 
primary infection during early pregnancy are at great risk for neonatal morbidity and mortality. 
Additionally, congenital CMV infection is a leading cause of neonatal morbidity. Women in the 
reproductive age group had seroprevalence rates ranging from 40 % to 83 % in the United States 
(Johnson & Anderson, 2013). In the present study, CMV seropositive rates were 60.1 %.  
           CMV has been indicated as a cell-mediated immune function marker and is linked to 
stress. In this study, there were no significant relationships among stress, CMV titers and 
depression in pregnant women. Pregnancy is an immunologically weak period and therefore 
pregnant women are vulnerable to herpes viral reactivation. Cancer patients and older adults 
show similar weakness in their immune system. The current study finding was similar to 
Fagundes and colleagues (2012) whose study reported that there were no associations between 
depression and CMV or EBV titers in women with breast cancer. Contrarily, Phillips and 
colleagues (2008) reported that higher CMV antibody titers were associated with depression and 
anxiety in older adults. 
           Further exploratory analysis showed that CMV seropositive titers were associated with 
fatigue symptoms (POMS-F). Separate Pearson correlation and regression analyses were 
conducted to examine relationships among perceived stress, depressive and fatigue symptoms in 
this study population. The results revealed that fatigue symptoms were correlated with 
depressive symptoms and perceived stress. Perceived stress strongly predicted fatigue symptoms 
after controlling for depressive symptoms, race and number of children in this population. 
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           The important finding from this study was that CMV seropositive titers were significantly 
positively correlated with POMS-F score. Women with higher CMV seropositive titers had 
greater fatigue symptoms. This relationship remained strong after controlling for race, number of 
children, perceived stress and depressive symptoms. This prenatal study did not reveal 
significant relationships between fatigue and other herpes viral titers (HSV-1, HSV-2, HHV-6 or 
EBV).  
           Findings from this study are particularly exciting because they indicate a relationship 
between CMV seropositive titers and fatigue symptoms that has previously been unreported for a 
population of healthy pregnant women. Fatigue is a growing problem in public health. It has a 
negative impact on individual health and quality of life. It is estimated that 40 % of individuals 
complain of fatigue symptoms in primary care offices (Bower, 2012). Recently, the 
psychoneuroimmunology field has put emphasis on fatigue research to understand how neuro- 
immune system interactions affect fatigue symptoms. 
           Fagundes and colleagues (2012) reported that woman with breast cancer with higher 
CMV seropositive titers, but not the EBV titers, had greater fatigue symptoms. Other CMV 
related studies, such as Jaremka and colleagues (2013), reported that loneliness predicts pain, 
depression and fatigue which were related to CMV reactivation, not EBV. Although Fagundes 
(2012) and Jaremka (2013) reported CMV seropositive titers were related to fatigue symptoms, 
their studies only examined women with breast cancer not the general population of healthy 
pregnant women.  
           Bower and colleagues (2002) reported that people with increased persistent fatigue had 
higher levels of pro-inflammatory cytokine activity, such as increase IL-1 receptor antagonist 
(IL-1ra), soluble tumor necrosis factor receptor type II (sTNF-RII)  and neopterin in cancer 
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patients. Bellmann-Weiler and colleagues (2008) reported that IFN-γ mediated tryptophan 
depleted in fatigue patients with EBV infection. Ross and colleagues (2009) reported that HIV 
positive pregnant women with more physical fatigue symptoms were associated with depression. 
Furthermore, chronic fatigue syndrome has been linked to herpes viral EBV infection (Bansal et 
al., 2012).  
           Bower (2012) proposed a model to demonstrate how inflammation and other factors 
influence fatigue symptoms. The model states that infection, radiation and cancer treatment 
triggers inflammation processing and induces fatigue symptoms. Other factors included in the 
fatigue model are genetic factors, neuroendocrine factors, psychosocial factors (e.g. stress and 
sleep), and immune factors (e.g. immune dysregulation or viral reactivation).  
           In conclusion, the current study found that prenatal perceived stress is related to CMV 
reactivation, which may involve neuroendocrine interactions different from those of other herpes 
viruses, and triggers fatigue symptoms. CMV seropositive titers play an important role in fatigue 
symptoms; therefore CMV could be an objective biomarker to assess fatigue symptoms in future 
study.   
           Human herpes virus-6 (HHV-6) and Epstein - Barr virus (EBV). In this study, the  
HHV-6 prevalence rate was 76.2 % and the EBV rate was 90.7 %. HHV-6 and EBV seropositive 
titers were unrelated to prenatal perceived stress or depressive symptoms, and thus HHV-6 and 
EBV are not discussed further.   
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Hypothesis 3: Perceived Stress, Herpes Viral Titers, Biogenic Amines, and Depressive 
Symptoms 
           Prenatal psychosocial stress and the normal physiology of pregnancy induce an immune 
shift from type 1 to type 2 which favors latent herpes viral reactivation. IDO activation and the 
inflammatory process during pregnancy reduce tryptophan availability and decrease viral 
replication. Consequently, serotonin synthesis decreases and dopamine synthesis from 
phenylalanine to tyrosine also decreases. Decreased tryptophan and serotonin or tyrosine and 
dopamine levels were related to prenatal depression (Scrandis et al., 2008). 
           In this study, POMS-D and perceived stress scores were negatively correlated with 
phenylalanine levels. The following immune markers and amino acid levels were positively 
correlated: (1) nitrite with phenylalanine, (2) neopterin with phenylalanine, kynurenine, Phe /Tyr 
and KYN /TRP ratios, (3) tryptophan with kynurenine, phenylalanine and tyrosine, and (4) 
phenylalanine with tyrosine. Tryptophan concentrations were negatively correlated with 
KYN/TRP ratios and KYN /TRP ratios were negatively correlated with phenylalanine and 
tyrosine. These results indicate that immune activation influences the amino acids metabolism. 
            Tryptophan and kynurenine. The independent t-test analysis in this study compared 
POMS-D scores > 20 depressed women to POMS-D scores ≤ 20 women indicated that POMS-D 
scores > 20 depressed women had a significantly lower tryptophan level. This finding was 
similar to that of Scrandis and colleagues (2008), who reported that prenatal depressive 
symptoms were negatively correlated with tryptophan levels.  
           Results from t-test analyses showed that the HSV-2 seropositive group had a significantly 
lower neopterin level which may indicate chronic inflammation (Capuron et al., 2011). The 
neopterin concentration is a marker for degree of immune activation (Murr, Widner, Wirleitner 
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& Fuchs, 2002). High neopterin level was associated with macrophage activation and 
inflammation (Sperner-unterweger, Kohl & Fuchs, 2012; Widner et al., 2002). Pearson 
correlation analysis showed negative correlations between seropositive herpes viral titers and 
biogenic amines: HSV-1 with tryptophan and phenylalanine; CMV with Phe /Tyr ratios; positive 
correlations between HHV-6 with tryptophan, kynurenine and phenylalanine. 
           The study results revealed that women with HSV-1 seropositive titers had lower 
tryptophan levels, but plasma kynurenine levels or KYN /TRP ratios did not increase. Women 
with HHV-6 seropositive titers had higher tryptophan and kynurenine levels. These results 
suggest that the IDO pathway may not activate in women with herpes viral infection or 
depressive symptoms. An alternative pathway may mediate tryptophan depletion, or dietary 
intakes may affect this metabolism pathway. This study finding was similar to Hughes and 
colleagues (2012), who reported no indication of kynurenine pathway activation in depressed 
patients.   
           Phenylalanine and tyrosine. This study also found that phenylalanine levels were lower 
in women with POMS-D > 20 and HSV-1 seropositive titers. Women with HHV-6 seropositive 
titers had higher phenylalanine levels. Phe /Tyr ratios were lower in women with CMV 
seropositive titers. Phenylalanine and the Phe /Tyr ratios were positively correlated with 
neopterin and nitrite was positively correlated with phenylalanine which suggests immune 
system was in activation status. The phenylalanine, Phe /Tyr ratios, and neopterin and nitrite 
findings may indicate that the immune system response to herpes virus infection varies with 
different status or through different metabolisms pathways. 
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           CMV seropositive titers and Phe /Tyr ratios. Multiple regression analysis showed Phe 
/Tyr ratios were negatively correlated to depressive symptoms among women with CMV 
seropositive titers after controlling for race, number of children, perceived stress and neopterin. 
The study results were similar to Capuron and colleagues (2011) who reported a decrease in 
phenylalanine and tryptophan levels in elderly persons with depressive symptoms. 
           The Phe /Tyr ratio may indicate a dopamine synthesis biomarker (Neurauter et al., 2008). 
The dopamine precursor amino acid, tyrosine, is converted from phenylalanine. Basal ganglia 
neurotransmitter dopamine regulates a person’s motivation and motor activity which are related 
to fatigue or depressive symptoms. Increased plasma Phe /Tyr ratio indicated a decrease in 
phenylalanine 4-hydroxylase (PAH) enzyme activity which might indicate increased oxidative 
stress and inflammation. 
           The study results indicated lower phenylalanine levels and Phe /Tyr ratios in women with 
the herpes viral infection. These results were different from other literature. For example, Felger 
and colleagues (2013) reported that plasma Phe /Tyr ratios were significantly increased in 
hepatitis C patients with IFN-α treatment. Zangerle and colleagues (2010) reported that blood 
Phe /Tyr ratios were increased in patients with HIV-1 infection.  
            The difference in these results could be due to only using a single blood sample test 
which makes it difficult to assess inflammation and metabolism status or alternative pathways 
between PAH to tyrosine or tyrosine to L-dopa activity. This altered biosynthesis processing of 
5, 6, 7, 8-tetrahydrobiopterin (BH4) transfers hydrogen atoms to molecular oxygen and then to 
quinonoid 7, 8-dihydrobiopterin (BH2) (Neurauter et al., 2008). BH4 is an enzyme cofactor for 
formation of monoamine neurotransmitters serotonin, dopamine, norepinephrine and 
epinephrine. BH4 also shared a second pathway with folate (Miller, 2008; Neurauter et al., 
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2008). Thus, nutrition supplement of folate or vitamin B12 and antioxidant vitamins C and E 
may influence this pathway during pregnancy. 
Limitations of the Study  
           There are several limitations in this study:  
           First, this is a cross-sectional study with only a single blood sample test which limits the 
ability to draw conclusions about the direction of causality. A longitudinal study is needed to 
carefully describe herpes viral reactivation and investigate relationships between herpes viral 
reactivation and the IDO pathway in prenatal depression.  
           Second, the conceptual framework and hypothesis of the current study were based on a 
review of existing literature. The growing literature supports a role for stress induced immune 
shifting from Th1 to Th2 immunity. The immune effect theoretically reactivated the latent herpes 
virus and caused an imbalance of neurotransmitters. The current study outcome is that the herpes 
virus (HSV-2) was a mediator and had a partially mediating effect on the influence of perceived 
stress on depressive symptoms in pregnant women. The outcome of the study supports the 
proposed conceptual frame work and hypothesis. A reversed causality is possible in which 
depressive symptoms induce herpes viral reactivation. Future research is needed to explore 
different pathways among stress, herpes viral reactivation and depressive symptoms.  
           Third, the study data set was limited to a total of 380 out of the 631 pregnant women 
recruited from the original R01 study. The HSV-2 seropositive sample included only 83 cases. 
Future study may recruit more HSV-2 seropositive women.  
           Fourth, the POMS-D was a self- report questionnaire to measure mood status from the 
previous week. The POMS-D questionnaire is a general screening tool for clinical depressive 
symptoms. Different tools to repeat mood distress assessment during pregnancy are needed; such 
86 
 
as the Edinburgh Postnatal Depression Scale (EPDS), the Patient Health Questionnaire-9 (PHQ-
9), the Beck Depression Inventory (BDI), and the Epidemiological Studies Depression Scale 
(CES-D) (Nylen et al., 2013). 
           Fifth, some data on the women with depressive symptoms (POMS-D > 20) and herpes 
viral seropositivity were not available to analyze; for example, demographics data, sleep pattern, 
nutrition and clinical assessment. More socioeconomic and clinical assessments data would be 
needed for future study to improve identification of potential risk factors of prenatal depression.  
           Sixth, immune status data (e.g. cytokines, cortisol and other biomarkers) and herpes viral 
seroprevalence (e.g. primary or recurrence) were limited from R01 study. Pregnant women’s 
immune status and the herpes viral status should be included in future studies to better 
understand mechanisms of the relationships among prenatal stress, herpes viral reactivation and 
depression.     
           Finally, psychosocial stress has been found to be a significant predictor of depression and 
fatigue among herpes viral seropositive individuals. Therefore, to identify psychosocial stress, 
screening of herpes viral seroprevalence should be included and tools to assess fatigue symptoms 
are needed in future research. 
Implications for Future Research 
           The outcome of this study is significant for practicing clinicians because they will be able 
to identify risk factors (demographic, psychosocial, herpes viral titers, biomarkers) and assess 
potential prenatal depression or potential postpartum depression and herpes viral infection during 
routine obstetric care. However, there are still gaps in knowledge that need to be addressed. 
           Screening tests to prevent the maternal herpes viral infection or depression are very 
important in public health, not only in maternal health but also in neonatal health. There is 
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insufficient data to support a recommendation screening for depression or routine herpes viruses 
(HSV-1, HSV-2, HHV-6, CMV, and EBV) in current clinical obstetric care. It is important to 
detect and prevent fetal damage and long-term adverse outcomes for subclinical state viral 
infection during pregnancy.  
           The study results provide an opportunity for important future research. Future research 
will continue to provide clinicians with a precise outline of how prenatal stress and psychosocial 
factors play a role in immune activation, promote herpes viral reactivation, and lead to 
depression or adverse pregnancy outcomes such as preterm delivery. 
           Future research could be done with longitudinal studies over different trimesters on 
maternal psychosocial risk factors, physical wellbeing, and pro-inflammatory biomarkers such as 
viral DNA. Maternal-neonatal outcomes data collection could add great value for future study. 
Moreover, based on results of this study, HSV-2 and CMV seropositive titers could be the 
objective biomarkers to assess depression and fatigue symptoms in future research. 
           The pregnant women were not informed of their own herpes viral infection status, or 
possibility of recurrence and methods of prevention efforts in the current study. Further research 
data will reinforce the need for proactive stress reduction through healthy behaviors such as 
sleep, exercise, and stopping smoking. Clinicians can provide better education to patients to 
encourage these behaviors. These could lead to reduced herpes virus recurrence rates and 
prevention of prenatal depression and neonatal herpes viral infection.   
           The current study outcome also builds a foundation in future psychoneuroimmunology 
research on stress, depression and herpes viral infection among different populations with 
immunosuppression such as elderly adults, caregivers, and individuals with HIV/AIDS, 
autoimmunity or organ transplantation.  
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Appendix A: Demographic Form 
Last Name: First Name: Initial: 
   
DOB: 
_____/_____/_____ 
 
Due 
Date:____/____/____
_ 
 
 
Pre-Pregnancy 
Wt:______ 
Today’s Weight: 
_______ 
Address:   
Street:_____________________
____ 
City:____________ 
State:_______ 
Zip Code: ____________  
 
Ht: _______     BMI:_______ 
 
Phone Number: 
____________________ 
Home:_______________________
_____ 
Cell: 
_____________________________ 
Emergency Contact 
Name:_______________ 
Phone Number:_______________ 
Email:_______________________
__ 
 
Demographic Information   
Race/Ethnicity: 
o Caucasian 
o African-American 
o Asian/Pacific Islander 
o Native American 
o Hispanic Origin  ○ White    ○ Black 
o Other 
o Country of birth :  
______________ 
o Father of the baby ethnicity 
______________ 
Education: 
o Grammar 
School 
o Middle 
School 
o High 
School 
Graduate 
o College 
Graduate 
o Post 
Graduate 
o Type of 
work_____
____ 
Household Income (Yearly): 
o Under $4,999 
o $5,000-14,999 
o $15,000-24,999 
o $25,000-39,999 
o $40,000-69,999 
o $70,000+ 
Marital Status: 
o Single 
o Married 
o Divorced 
o Widowed 
Current 
Working Status: 
o Part time 
o Full time 
o Not at all 
Hours/week:___
___ 
Number of 
Pregnancies: 
 
___ Total 
pregnancies 
___ Full Term 
___ Premature 
___ AB, induced 
___ AB, 
Spontaneous 
___ Ectopics 
___ Multiple 
Births 
___ Living 
How 
many 
children 
do you 
have? 
________
__ 
Number living 
in household: 
 
_________ 
110 
 
 
Medical History 
Do you Smoke? 
o Yes 
o No 
If Yes,  how many 
cigarettes/day:____
__ 
Did you smoke 
during your 
pregnancy? 
o Yes 
o No 
If Yes, how 
many 
cigarettes/day:_
___ 
Do you drink 
alcohol? 
o     None 
o 1 drink / week 
o 2-3 drinks / 
week 
o More than 2-3 
drinks /week  
 
 
Are you currently receiving any medical treatment for 
any health problems? If so please list. 
o No 
o Yes, please list 
 
 
 
 
 
                
 
 
 
Have you ever had severe eye inflammation?  When?  
o No 
o Yes ____________ 
 
Have you ever owned a cat?  When?  
              o No 
              o Yes ____________ 
Do you own a cat now?  
              o No 
              o Yes 
Do you ever eat very rare or raw meat? 
              o No 
              o Yes 
How many years have you lived in the U.S.? _________ 
What other countries have you lived in? How long for 
each country? 
_________________         ___________ 
_________________         ___________ 
_________________         ___________ 
_________________         ___________ 
Have you ever been diagnosed with Toxoplasmosis?  
          o No 
Are you taking any prescription 
medications? 
o No 
o Yes, please list 
 
1. 
 
2. 
 
3. 
 
4. 
 
1. 
 
2. 
 
3. 
 
4. 
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          o Yes   ________   When? ___________ 
What were your symptoms?  
______________________    _____________________ 
______________________    _____________________ 
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          Appendix B: Perceived Stress Scale 
 
  
         Stress Since We Last Visited with You       
Study ID #: _____________                                                                           Date: _________________ 
The questions in this scale ask you about your feelings and thoughts since we last visited with you. In each case, you 
will be asked to indicate how often you felt or thought a certain way.  Although some of the questions are similar, 
there are differences between them and you should treat each one as a separate question.  The best approach is to 
answer each question fairly quickly.  That is, don’t try to count up the number of times you felt a particular way, but 
rather make a reasonable estimate.  
Please check the correct answer: 
1 = Never        2 = Almost never     3 = Sometimes        4 = Fairly often        5 = Very often 
 1 2 3 4 5 
How often have you been upset because of something that happened unexpectedly?      
How often have you felt that you were unable to control the important things in your life?      
How often have you felt nervous and “stressed”?      
How often have you dealt successfully with irritating life hassles?      
How often have you felt that you were effectively coping with important changes that were 
occurring in your life? 
     
How often have you felt confident about your ability to handle your personal problems?      
How often have you felt that things were going your way?      
How often have you found that you could not cope with all the things that you had to do?      
How often have you been able to control irritations in your life?      
How often have you felt that you were on top of things?      
How often have you been angered because of things that happened that were outside of 
your control? 
     
How often have you found yourself thinking about things that you have to accomplish?      
How often have you been able to control the way you spend your time?      
How often have you felt difficulties were piling up so high that you could not overcome 
them? 
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